Cardiomyopathy, other and unspecified

I9_CARDMYOOTH

cardiomyopathy: A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I42.8, I42.9 Hospital discharge: ICD-9 — 4259X Hospital discharge: ICD-8 — 425 Cause of death: ICD-10 — I42.8, I42.9 Cause of death: ICD-9 — 4259X Cause of death: ICD-8 — 425 2 out of 7 registries used, show all original rules.	3714
4. Check minimum number of events None	3714
5. Include endpoints None	3714
6. Filter based on genotype QC (FinnGen only)	3306

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	I9_CARDMYOOTH
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I428\|I429
HD_ICD_9	4259X
HD_ICD_8	425
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I428\|I429
COD_ICD_9	4259X
COD_ICD_8	425
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiomyopathy, other and unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23467	8732	14423
Only index persons	17151	6748	10403
Unadjusted period prevalence (%)
Whole population	0.35	0.25	0.40
Only index persons	0.34	0.25	0.40
Median age at first event (years)
Whole population	60.50	63.47	58.75
Only index persons	60.78	63.42	59.07

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3306	1362	1944
Unadjusted period prevalence (%)	0.72	0.48	0.89
Median age at first event (years)	60.40	61.07	59.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3400: Matched controls
34000

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

+∞

320.0

302

WX892

NOMESCO Finland

Monitored bed care

6.6

312.7

563

997

C09AA05

ATC

ramipril; oral

6.6

307.7

1801

4988

GD1LA

NOMESCO Finland

162.6

307.7

297

I50

ICD-10 Finland

Heart failure

73.2

307.7

319

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.3

307.7

2284

10910

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

307.7

1492

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

702.5

307.7

845

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

208.6

307.7

215

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

307.7

320

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

20.6

307.7

1924

2028

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

612.7

307.7

1027

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1032.7

307.7

732

207

Kela drug reimbursment

Chronic arrhythmias

985.3

307.7

1248

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

10.7

307.7

656

745

C03DA01

ATC

spironolactone; oral

23.2

307.7

1630

1298

I47.1

ICD-10 Finland

Supraventricular tachycardia

47.4

307.7

222

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

11.9

307.7

498

482

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

55.5

307.7

257

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

137.5

307.7

301

C07AB07

ATC

bisoprolol; oral

13.2

307.7

2807

8967

K78

ICPC

Atrial fibrillation/flutter

39.2

307.7

497

148

250, ,

Kela drug reimbursment

218.9

307.7

388

I47.2

ICD-10 Finland

Ventricular tachycardia

766.5

307.7

465

I48

ICD-10 Finland

Atrial fibrillation and flutter

240.1

307.7

1534

116

C07AA07

ATC

sotalol; systemic

17.1

307.7

290

184

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

144.3

307.7

440

I50.1

ICD-10 Finland

Left ventricular failure

3291.6

307.7

1004

I42.8

ICD-10 Finland

Other cardiomyopathies

+∞

307.7

786

C01AA05

ATC

digoxin; systemic

71.1

307.7

819

151

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

744.1

307.7

999

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

143.6

307.7

177

C03CA01

ATC

furosemide; systemic

11.7

307.7

2195

4573

I50.9

ICD-10 Finland

Heart failure, unspecified

214.3

307.7

1684

155

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

913

AN1

Coronary angiography

9.4

307.7

1001

1440

I48.2

ICD-10 Finland

Chronic atrial fibrillation

513.6

307.7

327

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

11.7

307.7

1681

2629

XF404

NOMESCO Finland

Ambulatory ECG

27.7

307.7

932

458

B01AF02

ATC

apixaban; oral

12.8

307.7

731

715

C01BD01

ATC

amiodarone; systemic

568.1

307.7

528

TFP20

NOMESCO Finland

Cardiodefibrillation

521.3

307.7

636

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

151.6

307.7

448

I49.5

ICD-10 Finland

Sick sinus syndrome

210.7

307.7

217

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

185.4

307.7

273

XF400

NOMESCO Finland

ECG with 12 standard connections

4.8

307.7

959

2578

201

Kela drug reimbursment

Chronic cardiac insufficiency

180.8

307.7

1529

153

I48.1

ICD-10 Finland

Persistent atrial fibrillation

185.0

307.7

288

K77

ICPC

Heart failure

55.5

307.7

228

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

307.7

374

I50.0

ICD-10 Finland

Congestive heart failure

462.9

307.7

939

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.7

307.7

1130

2727

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

4503599627370496.0

307.7

2600

C09DX04

ATC

valsartan and sacubitril; oral

+∞

307.7

359

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

156.9

307.7

377

B01AA03

ATC

warfarin; systemic

17.9

307.7

1505

1443

I49.3

ICD-10 Finland

Ventricular premature depolarization

18.3

307.7

449

280

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

108.1

307.7

269

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

12.8

307.7

2023

3509

C01BC04

ATC

flecainide; systemic

116.7

306.2

156

XF640, ,

NOMESCO Finland

18.2

281.8

230

135

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

967.9

277.0

268

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

6.4

273.1

500

896

I44.2

ICD-10 Finland

Atrioventricular block, complete

2681.1

271.3

259

XF402

NOMESCO Finland

ECG with work load test

5.3

268.4

618

1368

AP1

Catheterization of the left side of the heart

19.9

266.3

208

111

R06.0

ICD-10 Finland

Dyspnoea

3.6

260.1

1271

4882

TFP34

NOMESCO Finland

Electrophysiological investigation

669.3

254.9

249

Z2221

NOMESCO Finland

Medical doctor

3.4

254.2

1350

5450

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

862.7

248.2

241

I35.0

ICD-10 Finland

Aortic (valve) stenosis

23.1

243.7

178

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

7.8

239.0

352

499

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

10.7

230.9

259

260

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.5

229.6

1080

4003

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

227.7

216

I34.1

ICD-10 Finland

Mitral (valve) prolapse

66.0

220.4

121

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

20.9

219.2

167

Angiography of the heart and coronary arteries

6.3

218.8

394

690

A10BK01

ATC

dapagliflozin; oral

4.9

217.0

538

1257

K84

ICPC

Heart disease other

11.4

217.0

232

217

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

23.1

215.3

157

ZXD05

NOMESCO Finland

Urgent procedure

3.1

212.2

1329

5802

M04AA01

ATC

allopurinol; systemic

3.9

209.3

745

2284

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

15.4

207.8

184

126

ZXE00

NOMESCO Finland

One hour or less

2.9

201.8

1667

8422

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

1933.3

200.9

193

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

5.2

200.3

456

989

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

95.6

195.7

102

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.6

194.5

397

781

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

1995.4

186.1

179

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

7.4

179.9

271

392

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

176.6

168

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

175.6

167

TPH07

NOMESCO Finland

Cathetrisation of artery

3.7

172.4

632

1959

FL1AC

NOMESCO Finland

Left cardioangiography

13.9

172.3

161

121

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

162.8

155

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

159.6

152

WX872

NOMESCO Finland

Intensive care

6.1

159.4

293

520

R4110

NOMESCO Finland

Physiotherapy

2.7

158.8

1269

6129

Z3231

NOMESCO Finland

Registered nurse

2.7

153.2

1224

5891

ZX120

NOMESCO Finland

Intravenous

3.8

152.4

527

1562

XFE00

NOMESCO Finland

Epicardial ultrasonography

12.8

152.1

149

121

ZXD10

NOMESCO Finland

Scheduled procedure

2.6

152.0

1573

8568

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

146.9

140

A12BA01

ATC

potassium chloride; oral

6.5

144.5

246

404

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

142.1

972

4299

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

345.4

133.6

134

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.0

133.1

739

2914

TFP35

NOMESCO Finland

Electroanatomical mapping

455.1

133.0

132

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.5

132.4

527

1706

TFJ02

NOMESCO Finland

Muscle biopsy of heart

1328.7

132.2

128

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

132.1

126

M10.9

ICD-10 Finland

Gout, unspecified

4.0

129.3

402

1101

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

128.2

821

3488

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

20.0

128.1

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

20.8

127.8

127

Kela drug reimbursment

Transplant complication

10.3

125.9

143

145

I42

ICD-10 Finland

Cardiomyopathy

+∞

124.8

119

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

40.3

123.4

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

122.6

117

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.5

122.2

998

4767

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

9.8

121.6

143

152

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

614.5

121.0

119

C07AG02

ATC

carvedilol; oral

4.3

120.5

332

830

C07AB02

ATC

metoprolol; systemic

2.7

120.0

784

3353

1CX08, ,

NOMESCO Finland

212.6

119.5

123

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

118.5

1426

8075

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

117.4

1086

5478

42509

ICD-8 Finland

Cardiomyopathy, Unspecified

+∞

117.4

112

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

115.3

110

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

156.8

115.0

121

Z3226

NOMESCO Finland

Physiotherapist

2.7

114.9

807

3571

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

43.3

113.8

B01AF03

ATC

edoxaban; oral

19.0

112.8

L04AA06

ATC

mycophenolic acid; systemic

8.3

112.5

151

190

XF409

NOMESCO Finland

Other special ECG

63.1

111.9

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

4.4

110.7

296

722

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

+∞

110.0

105

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

107.9

103

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

107.7

1109

5826

B01AE07

ATC

dabigatran etexilate; oral

7.5

106.7

155

214

Z94.1

ICD-10 Finland

Heart transplant status

225.1

106.2

109

R02

ICPC

Shortness of breath/dyspnoea

2.9

105.2

565

2166

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.0

105.2

237

503

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

528.8

104.2

103

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

6.6

103.5

170

268

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.4

101.2

410

1332

C08DA01

ATC

verapamil; systemic

6.3

99.2

170

280

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

98.4

C01DA14

ATC

isosorbide mononitrate; oral

2.7

97.3

604

2493

A10BK03

ATC

empagliflozin; oral

2.9

94.1

496

1875

AP4

Myocardial biopsy

933.5

93.3

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

53.8

92.8

R00.1

ICD-10 Finland

Bradycardia, unspecified

6.9

92.2

144

215

K99

ICPC

Cardiovascular disease other

7.0

92.2

143

212

B01AB05

ATC

enoxaparin; parenteral

2.1

89.4

1197

6895

TK800

NOMESCO Finland

Hemodialysis

6.9

88.4

139

209

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

87.9

306

899

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

87.9

I44.1

ICD-10 Finland

Atrioventricular block, second degree

157.5

87.5

AA1AD

NOMESCO Finland

CT of head and brain

2.1

86.2

1120

6361

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.4

86.0

341

1089

I25.2

ICD-10 Finland

Old myocardial infarction

3.7

85.5

285

813

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.3

85.2

178

353

L04AD02

ATC

tacrolimus; systemic

10.4

84.0

I51.4

ICD-10 Finland

Myocarditis, unspecified

838.7

83.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

83.3

563

2411

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

82.6

3AC01, ,

NOMESCO Finland

12.1

82.5

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

81.6

H02AB06

ATC

prednisolone; systemic

2.0

80.3

1686

11305

N19

ICD-10 Finland

Unspecified kidney failure

4.7

78.9

188

417

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.8

78.6

256

718

AS4

Physiological pacemaker insertion DDD (R)

+∞

78.4

AQ1

Conventional electrophysiological examination

+∞

77.4

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

15.5

76.9

AS7

Arrhythmia pacemaker insertion VVI (R) S

765.3

76.6

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

76.5

556

2458

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.3

76.0

669

3223

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

75.3

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

7.2

75.1

113

162

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.4

73.3

275

846

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

73.2

Z2446

NOMESCO Finland

Social worker

3.3

73.1

295

950

K80

ICPC

Cardiac arrhythmia NOS

3.5

72.8

270

825

WX722

NOMESCO Finland

PEEP

3.8

71.9

228

627

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

71.1

A46

ICD-10 Finland

Erysipelas

2.4

70.4

595

2808

C09AA04

ATC

perindopril; oral

3.5

70.2

262

803

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

+∞

70.0

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

681.7

68.2

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

+∞

67.9

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

17.5

67.1

R55

ICD-10 Finland

Syncope and collapse

2.6

66.1

437

1839

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

333.5

65.7

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.6

65.4

228

668

Electrophysiological Special Examination

640.1

64.1

I44.0

ICD-10 Finland

Atrioventricular block, first degree

14.8

64.0

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.5

63.9

228

678

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.9

63.3

115

200

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.2

63.2

133

265

TK810

NOMESCO Finland

Hemofiltration

14.6

62.2

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

+∞

61.6

WX730

NOMESCO Finland

Conventional respirator

7.5

61.5

122

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.1

61.3

107

179

ZX108

NOMESCO Finland

Inhalation

10.5

60.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

60.3

385

1590

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

5.6

60.2

115

210

XF600

NOMESCO Finland

Bloodpressure measurement

3.2

60.1

257

855

E87.5

ICD-10 Finland

Hyperkalaemia

6.4

60.0

101

163

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.3

59.9

157

375

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

59.9

686

3642

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

59.8

343

1342

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

6.0

59.5

106

181

I20.09

ICD-10 Finland

Unstable angina

3.3

58.4

231

733

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

58.3

435

1932

WX740

NOMESCO Finland

Nitrogen oxide therapy

126.3

58.0

M10

ICD-10 Finland

Gout

3.4

57.6

219

678

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

57.5

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

57.5

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

56.4

651

3459

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

56.2

954

5796

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

55.5

652

3485

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.0

55.2

162

421

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

55.2

299

1135

A11CC03

ATC

alfacalcidol; systemic

5.2

55.0

114

224

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

5.0

54.9

121

251

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

546.7

54.7

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.5

54.4

106

197

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

54.3

908

5478

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

54.3

M10.0

ICD-10 Finland

Idiopathic gout

3.8

54.2

170

463

C09AA02

ATC

enalapril; systemic

2.0

54.0

720

4024

B01AF01

ATC

rivaroxaban; oral

2.4

53.8

414

1861

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

+∞

53.3

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

53.3

Initial pacemaker installation

+∞

53.3

I49.1

ICD-10 Finland

Atrial premature depolarization

6.3

52.8

147

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.0

52.6

242

839

42508

ICD-8 Finland

Cardiomyopathy, Alia definita

+∞

52.2

I45.9

ICD-10 Finland

Conduction disorder, unspecified

84.4

52.0

R04.0

ICD-10 Finland

Epistaxis

2.8

51.8

287

1101

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.3

51.2

205

655

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

50.7

426

1987

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.5

50.7

179

528

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

50.1

429

2018

Z50.0

ICD-10 Finland

Cardiac rehabilitation

8.3

50.1

AP2

Catheterization of the right side of the heart

93.2

49.9

WX882

NOMESCO Finland

High dependency care

4.2

49.9

138

343

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

49.1

N18.8

ICD-10 Finland

Other chronic renal failure

4.9

47.8

107

225

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.0

47.7

225

791

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

47.6

989

6339

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

6.3

47.2

130

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.7

46.3

263

1021

AP3

Catheterization of the right and left side of the heart

238.2

46.1

C10AA05

ATC

atorvastatin; oral

1.7

46.1

1500

10862

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.4

45.6

339

1496

A02BC02

ATC

pantoprazole; systemic

1.7

45.2

2256

18223

C08DB01

ATC

diltiazem; oral

3.2

45.0

186

605

L04AX01

ATC

azathioprine; systemic

3.4

44.9

171

529

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

44.9

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

+∞

44.9

R53

ICD-10 Finland

Malaise and fatigue

1.8

44.7

778

4712

C10AA01

ATC

simvastatin; oral

1.7

44.5

1484

10782

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.1

44.4

128

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

+∞

43.8

RS221, ,

NOMESCO Finland

5.8

43.8

140

H03BB01

ATC

carbimazole; oral

3.5

43.4

151

441

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

43.3

189

635

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

433.1

43.3

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

+∞

42.8

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.0

42.7

192

656

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.8

42.4

133

362

S97

ICPC

Chronic ulcer skin

2.7

41.9

240

935

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

41.8

867

5518

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

+∞

41.7

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.7

41.6

230

880

PD5AD

NOMESCO Finland

CT of aorta

4.8

41.4

204

Cardiac muscle biopsy

+∞

40.7

R03AC02

ATC

salbutamol; inhalant

1.6

40.2

1661

12623

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

40.1

375

1821

L04AD01

ATC

ciclosporin; systemic

4.8

40.0

190

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

39.8

234

923

WX002

NOMESCO Finland

Sedation and analgesia

1.8

39.8

665

3962

N02AX02

ATC

tramadol; systemic, rectal

1.6

39.7

1435

10547

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

39.7

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

39.7

Catheterization and pressure measurement of the left side of the heart

5.5

39.6

143

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

4.0

39.5

113

288

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.9

39.1

189

673

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.5

38.6

134

391

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

38.4

270

1160

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

12.9

38.3

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

38.3

551

3126

7AX01, ,

NOMESCO Finland

381.7

38.1

R03BB04

ATC

tiotropium bromide; inhalant

2.2

38.1

367

1802

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

11.2

38.0

3A064, ,

NOMESCO Finland

85.1

37.9

I20.00

ICD-10 Finland

Unstable angina

3.9

37.8

114

302

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.6

37.4

127

365

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

37.4

585

3408

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.0

37.3

173

602

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

371.4

37.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.7

36.8

205

787

I48.3

ICD-10 Finland

Typical atrial flutter

131.5

36.8

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

+∞

36.5

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.5

36.5

247

1042

N17.8

ICD-10 Finland

Other acute renal failure

6.0

36.4

108

J01FF01

ATC

clindamycin; systemic

1.7

36.3

852

5580

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

35.8

1092

7648

AS2

Ventricular pacemaker insertion VVI (R)

+∞

35.5

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.8

35.0

177

645

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

35.0

217

878

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.7

34.5

194

748

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

+∞

34.4

Catheter ablation of arrhythmia

+∞

34.4

I48.4

ICD-10 Finland

Atypical atrial flutter

+∞

34.4

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

+∞

34.4

N05CF01

ATC

zopiclone; oral

1.6

34.3

1042

7274

R2110

NOMESCO Finland

Giving the first information

2.6

34.1

209

841

E05.89

ICD-10 Finland

Other thyrotoxicosis

42.5

34.0

132

Kela drug reimbursment

Sarcoidosis

8.4

33.9

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

33.8

357

1812

H02AB07

ATC

prednisone; oral

1.9

33.5

454

2516

342

Kela drug reimbursment

Dronedarone

+∞

33.4

Initial installation of the atrial pacemaker

+∞

33.4

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

10.7

33.1

PD5BD

NOMESCO Finland

Extensive CT of aorta

5.1

33.0

137

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.4

32.9

121

366

C09AA01

ATC

captopril; oral

4.8

32.5

158

K83

ICPC

Heart valve disease NOS

37.7

32.5

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

32.3

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

32.2

921

6316

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

32.0

2357

26618

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.0

31.9

361

1879

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

31.9

158

570

R4190

NOMESCO Finland

Nutritional therapy

2.9

31.8

156

560

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

6.8

31.4

R50.9

ICD-10 Finland

Fever, unspecified

1.9

31.4

485

2803

AQ2

Electrophysiological electroanatomical examination

+∞

31.3

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

31.3

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

31.3

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

31.3

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.2

31.2

275

1300

Catheterization and pressure measurement of the right side of the heart

60.6

31.1

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

42.6

30.9

J01MA12

ATC

levofloxacin; systemic

1.7

30.8

613

3815

A10AE04

ATC

insulin glargine; parenteral

2.1

30.8

332

1696

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

30.7

702

4538

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

30.2

A10AB05

ATC

insulin aspart; parenteral

2.2

30.2

259

1211

I11

ICD-10 Finland

Hypertensive heart disease

11.6

30.0

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

5.4

29.9

111

WX890

NOMESCO Finland

Intesive care monitoring

7.8

29.8

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

34.9

29.6

TFN04, ,

NOMESCO Finland

10.8

29.6

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.3

29.4

231

1041

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

29.2

42500

ICD-8 Finland

Cardiomyopathy, Stenosis subaortae hypertrophicans

+∞

29.2

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

29.2

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

29.2

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

29.2

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.5

29.1

103

742, ,

NOMESCO Finland

80.8

28.8

J01CA04

ATC

amoxicillin; systemic

1.6

28.8

2512

21827

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.0

28.7

130

446

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

28.5

135

475

K04

ICPC

Palpitations/awareness of heart

2.9

28.5

136

481

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

6.8

28.4

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.7

28.3

257

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

28.2

1006

7226

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

28.2

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

+∞

28.2

WX930

NOMESCO Finland

Thepapeutic hypothermia

+∞

28.2

R4120

NOMESCO Finland

Occupational therapy

2.3

28.0

232

1069

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

27.9

1298

9870

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

27.8

153

583

G04BE03

ATC

sildenafil; oral

3.7

27.8

246

K29

ICPC

Cardiovascular sympt/complt other

2.7

27.7

155

596

A10AC01

ATC

insulin (human); parenteral

2.2

27.7

238

1113

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

6.3

27.4

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.1

27.3

113

368

J01DB01

ATC

cefalexin; oral

1.6

27.2

2611

22993

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

+∞

27.1

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

+∞

27.1

XFP02, ,

NOMESCO Finland

+∞

27.1

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

+∞

27.1

ZXA05

NOMESCO Finland

Left side

1.6

27.1

782

5340

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

26.9

385

2166

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

273.2

26.8

K05

ICPC

Irregular heartbeat other

3.7

26.7

239

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

141.1

26.6

L04AA01

ATC

[U] ciclosporin

4.7

26.6

135

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.2

26.6

109

353

C01BA03

ATC

disopyramide; systemic

46.1

26.5

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

26.3

835

5826

C03AA03

ATC

hydrochlorothiazide; oral

2.1

26.2

280

1424

C01BD07

ATC

dronedarone; oral

+∞

26.1

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

26.1

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

+∞

26.1

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.8

25.8

130

473

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.4

25.7

269

Z71.8

ICD-10 Finland

Other specified counselling

1.5

25.7

991

7212

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

22.0

25.6

GEA00

NOMESCO Finland

Mediastinoscopy

10.1

25.6

N18.0

ICD-10 Finland

End-stage renal disease

6.6

25.5

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

25.3

215

1000

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

25.2

187

822

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

25.0

575

3705

R04.2

ICD-10 Finland

Haemoptysis

2.7

24.6

130

485

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

24.6

1330

10345

C01BA01

ATC

quinidine; oral

43.2

24.6

C01BB02

ATC

mexiletine; systemic

48.7

24.3

B01AB04

ATC

dalteparin; parenteral

2.4

24.0

176

769

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

+∞

24.0

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

24.0

XF406

NOMESCO Finland

High resolution ECG

+∞

24.0

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

+∞

24.0

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

+∞

24.0

4251A

ICD-9 Finland

Cardiomyopathy, Hypertrophic obstructive cardiomyopathy

+∞

24.0

4270A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia

+∞

24.0

I51.8

ICD-10 Finland

Other ill-defined heart diseases

+∞

24.0

UJF32

NOMESCO Finland

Coloscopy

1.5

23.9

821

5811

I51.9

ICD-10 Finland

Heart disease, unspecified

67.9

23.8

C09CA03

ATC

valsartan; oral

1.9

23.8

313

1710

I45.6

ICD-10 Finland

Pre-excitation syndrome

241.6

23.7

FXE00

NOMESCO Finland

Use of ECLA

241.6

23.7

3025

Kela drug reimbursment

Calcium carbonate

8.6

23.6

FM1DE, ,

SPAT

33.6

23.3

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

23.3

234

1162

A10BA02

ATC

metformin; oral

1.5

23.1

927

6775

C07AB03

ATC

atenolol; systemic

2.3

23.0

175

777

A28

ICPC

Limited function/disability NOS

1.6

22.9

581

3827

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

+∞

22.9

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.5

22.9

225

ZXE90

NOMESCO Finland

More than 22 hours

7.1

22.9

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.2

22.8

200

942

M01AH05

ATC

etoricoxib; oral

0.7

22.8

1353

16591

A12AA04

ATC

calcium carbonate; oral

4.3

22.7

136

ZXD00

NOMESCO Finland

Emergency procedure

3.0

22.7

103

354

WW200

NOMESCO Finland

Immunization

3.0

22.7

333

I44.6

ICD-10 Finland

Other and unspecified fascicular block

84.0

22.7

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

120.8

22.6

L28

ICPC

Limited function/disability (L)

1.6

22.5

604

4033

R42

ICD-10 Finland

Dizziness and giddiness

1.6

22.5

691

4762

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

4.3

22.3

134

N02BE01

ATC

paracetamol; systemic, rectal

1.6

22.2

2858

26048

J81

ICD-10 Finland

Pulmonary oedema

19.6

22.1

D86.0

ICD-10 Finland

Sarcoidosis of lung

4.6

21.9

111

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

21.9

AK1

HTX (heart transplant)

+∞

21.9

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

21.9

242

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.8

21.8

107

384

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

4.4

21.7

124

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.7

21.7

118

447

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

115.8

21.6

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

8.3

21.4

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.7

21.3

117

446

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

6.6

21.3

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

21.2

405

2474

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

21.2

251

1323

R07.3

ICD-10 Finland

Other chest pain

1.9

21.1

306

1723

RS220, ,

NOMESCO Finland

4.3

21.1

127

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

21.1

791

5683

T92

ICPC

Gout

3.1

21.0

284

I95.9

ICD-10 Finland

Hypotension, unspecified

3.9

20.9

163

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

60.4

20.9

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

+∞

20.8

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

+∞

20.8

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

20.8

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

+∞

20.8

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

+∞

20.8

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

20.8

I51.7

ICD-10 Finland

Cardiomegaly

+∞

20.8

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

+∞

20.8

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

21.6

20.8

XF602

NOMESCO Finland

Bloodpressure monitoring

4.5

20.8

112

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

20.7

151

658

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

20.7

128

517

WX902

NOMESCO Finland

External defibrillation of heart

77.3

20.7

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

20.7

151

659

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

20.7

399

2445

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

20.6

412

2548

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

20.6

209

1042

I47.0

ICD-10 Finland

Re-entry ventricular arrhythmia

110.7

20.6

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.0

20.5

147

J96.0

ICD-10 Finland

Acute respiratory failure

4.6

20.5

105

A10AE05

ATC

insulin detemir; parenteral

2.3

20.4

166

758

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

20.4

175

FM1CD

NOMESCO Finland

Very extensive CT of heart

48.3

20.1

K92.1

ICD-10 Finland

Melaena

2.2

20.1

175

822

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.4

20.1

115

C02EA01, ,

ATC

4.8

20.1

ZX197, ,

NOMESCO Finland

57.9

19.9

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

4.5

19.8

108

FPG04

NOMESCO Finland

Insertion of internal defibrillator, atrial and chamber electrode

+∞

19.8

ASA

Insertion of a biventricular pacemaker VVI (R) S

+∞

19.8

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

19.8

146

640

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.1

19.7

274

J94.8

ICD-10 Finland

Other specified pleural conditions

3.9

19.6

152

B01AC04

ATC

clopidogrel; oral

1.6

19.6

506

3340

WX402

NOMESCO Finland

General anaesthesia

1.5

19.5

651

4552

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.4

19.5

RS222, ,

NOMESCO Finland

4.3

19.2

115

R00.2

ICD-10 Finland

Palpitations

2.1

19.2

179

864

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

6.5

19.2

5AB14, ,

NOMESCO Finland

26.2

19.1

Z94.0

ICD-10 Finland

Kidney transplant status

4.5

18.9

104

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

34.5

18.9

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

18.9

156

718

XX3BW, ,

NOMESCO Finland

+∞

18.8

AB2

AVR bio, stent

+∞

18.8

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

+∞

18.8

AS5

Biventricular heart failure pacemaker insertion VVI (R)

+∞

18.8

AC4

MVP

+∞

18.8

I49.2

ICD-10 Finland

Junctional premature depolarization

70.3

18.7

5253

FHL

Cardiac lung machine

6.8

18.7

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

18.7

145

650

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

18.6

186

923

ZXA00

NOMESCO Finland

Right side

1.5

18.6

801

5899

E66.8

ICD-10 Finland

Other obesity

2.3

18.5

142

633

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.8

18.4

329

205

Kela drug reimbursment

Chronic hypertension

1.5

18.3

815

6035

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

18.3

190

956

AA1

Conventional CABG

3.5

18.3

179

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

18.2

311

1838

R60.0

ICD-10 Finland

Localized oedema

1.7

18.2

378

2358

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.0

18.2

133

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.6

18.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

18.1

438

2840

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

18.0

532

3616

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.9

18.0

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

18.0

104

407

C08CA02

ATC

felodipine; oral

1.8

18.0

289

1678

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

17.9

1074

8394

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

17.9

996

7683

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.9

17.8

301

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.7

17.8

158

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

17.7

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

+∞

17.7

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

17.7

111

452

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

17.7

367

2289

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

17.7

403

2576

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

17.6

147

680

I45.3

ICD-10 Finland

Trifascicular block

95.6

17.6

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

180.9

17.5

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

180.9

17.5

F1279, ,

NOMESCO Finland

180.9

17.5

I95.2

ICD-10 Finland

Hypotension due to drugs

5.9

17.4

NHQ40

NOMESCO Finland

Amputation of toe

3.6

17.4

156

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

28.9

17.4

FN1AD

NOMESCO Finland

CT of coronary arteries

3.4

17.4

180

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

24.1

17.3

K79

ICPC

Paroxysmal tachycardia

21.0

17.3

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.0

17.2

125

A10BH05

ATC

linagliptin; oral

2.1

17.2

162

785

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.2

17.2

206

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

17.2

182

922

XG466

NOMESCO Finland

Sleep oxymetry

2.6

17.2

370

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.4

17.1

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

16.9

260

1490

T90

ICPC

Diabetes non-insulin dependent

1.4

16.9

779

5794

A04

ICPC

Weakness/tiredness general

1.6

16.9

421

2750

N05BA01

ATC

diazepam; systemic, rectal

1.6

16.8

374

2375

XF622

NOMESCO Finland

Measurement of minute volume of heart

14.1

16.8

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

16.7

222

1215

RS230, ,

NOMESCO Finland

6.3

16.7

XW000

NOMESCO Finland

Bone marrow biopsy

2.2

16.7

134

609

C10AA03

ATC

pravastatin; oral

1.9

16.7

228

1259

R06

ICPC

Nose bleed/epistaxis

2.9

16.7

268

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

16.7

C01BC03

ATC

propafenone; systemic

+∞

16.7

R11

ICD-10 Finland

Nausea and vomiting

1.9

16.7

234

1304

C02DE01, ,

ATC

5.8

16.6

G47.3

ICD-10 Finland

Sleep apnoea

1.5

16.6

685

4989

3A149, ,

NOMESCO Finland

90.5

16.6

120, ,

NOMESCO Finland

170.8

16.5

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

16.5

251

1434

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

16.5

360

A07AA02

ATC

nystatin; oral

2.0

16.5

179

915

J01MA14

ATC

moxifloxacin; systemic

1.8

16.4

265

1541

C10AX09

ATC

ezetimibe; oral

1.5

16.3

524

3623

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

40.3

16.3

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.7

16.3

339

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.3

16.3

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

16.2

544

3795

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

16.2

1952

16956

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.8

16.2

131

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

16.1

215

1180

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

16.0

204

1101

212

Kela drug reimbursment

Gout

3.0

16.0

247

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

47.7

16.0

A10BB12

ATC

glimepiride; oral

1.9

16.0

207

1124

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

5.4

15.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

15.8

294

1779

J01AA02

ATC

doxycycline; systemic

1.4

15.8

2394

21513

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

15.8

100

410

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

5.0

15.7

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

5.5

15.7

E66.9

ICD-10 Finland

Obesity, unspecified

2.5

15.7

375

5CM18, ,

NOMESCO Finland

13.0

15.6

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

+∞

15.6

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

+∞

15.6

AT7

Replacing the pacemaker VVI (R) S

+∞

15.6

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

+∞

15.6

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.1

15.6

103

FXG00

NOMESCO Finland

Insertion and use of IABP

26.4

15.6

SPAT1263

SPAT

Sampling

1.4

15.5

1130

9067

SPAT1251

SPAT

Organisation of medication

2.5

15.5

383

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.1

15.5

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

160.7

15.5

E86

ICD-10 Finland

Volume depletion

2.7

15.4

303

2BD01, ,

NOMESCO Finland

38.2

15.4

TGC00

NOMESCO Finland

Bronchial lavation

2.6

15.3

344

WVA20

NOMESCO Finland

Medicine administration

2.5

15.3

374

A10BJ02

ATC

liraglutide; parenteral

2.6

15.2

345

Q23.11

ICD-10 Finland

Bicuspid aortic valve

16.1

15.2

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.4

15.2

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

4.4

15.2

A10BH01

ATC

sitagliptin; oral

1.7

15.1

305

1887

SPAT1097

SPAT

Recording of ECG

1.6

15.0

383

2513

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

15.0

1222

9970

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

15.0

384

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

14.9

161

821

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.3

14.9

114

509

A01

ICPC

Pain general/multiple sites

1.7

14.9

293

1801

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

12.5

14.8

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

14.8

232

1337

FM1AD

NOMESCO Finland

CT of heart

31.8

14.8

R18

ICD-10 Finland

Ascites

2.7

14.8

281

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

4.9

14.7

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.8

14.7

225

1288

J20

ICD-10 Finland

Acute bronchitis

1.7

14.7

281

1714

H02AB04

ATC

methylprednisolone; systemic

1.6

14.7

386

2550

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

21.1

14.6

FPH20

NOMESCO Finland

Removal of epicardial pacemaker or cardioverter-defibrillator

+∞

14.6

FPJ02

NOMESCO Finland

Revision of ventricular pacemaker generator

+∞

14.6

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

14.6

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

4.0

14.6

104

A41.8

ICD-10 Finland

Other specified sepsis

3.0

14.6

217

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.5

14.5

146

S18

ICPC

Laceration/cut

1.3

14.5

1452

12195

J01DA01

ATC

[U] cefalexin

1.3

14.5

1789

15483

AR5

Catheter ablation of arrhythmia, target: atrial flutter

150.6

14.5

C09CA01

ATC

losartan; oral

1.4

14.4

773

5884

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.2

14.4

128

607

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

14.4

254

1514

JN4AD

NOMESCO Finland

Body CT examination

1.6

14.4

362

2366

B03XA02

ATC

darbepoetin alfa; parenteral

2.8

14.4

246

I45.2

ICD-10 Finland

Bifascicular block

17.0

14.3

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

14.3

157

807

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.6

14.2

129

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

14.1

144

720

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

14.1

274

1677

Z82.4

ICD-10 Finland

Family history of ischaemic heart disease and other diseases of the circulatory system

6.4

14.1

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

5.0

14.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

14.0

373

2469

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.5

14.0

135

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

3.6

13.9

126

RD210, ,

NOMESCO Finland

3.1

13.9

191

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

13.8

208

1185

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.1

13.8

131

638

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.4

13.8

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

13.7

827

6416

GBB00

NOMESCO Finland

Tracheostomy

3.4

13.7

142

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

13.7

407

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

6.5

13.6

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

13.6

170

913

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

+∞

13.5

Aortic Valve Replacement (AVR)

+∞

13.5

I40.0

ICD-10 Finland

Infective myocarditis

+∞

13.5

X57

ICD-10 Finland

Unspecified privation

2.8

13.5

243

K60

ICPC

Cardiovascular, Result test/procedure

5.5

13.5

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

13.5

200

1133

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

13.5

181

995

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

13.4

211

1219

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.4

1151

9425

A06AD11

ATC

lactulose; oral

1.5

13.4

447

3110

WX213

NOMESCO Finland

Lower leg blockade

4.7

13.3

SPAT1260

SPAT

Consultation of another employee

1.5

13.3

461

3232

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.8

13.3

229

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

13.3

156

821

A10AD05

ATC

insulin aspart; parenteral

3.1

13.2

171

ZXA10

NOMESCO Finland

Bilateral

1.5

13.2

529

3817

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

5.1

13.1

SPAT1255

SPAT

Intravenous administration of medicine

1.8

13.1

191

1077

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

13.1

270

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

13.1

2120

18928

M10.3

ICD-10 Finland

Gout due to impairment of renal function

12.2

13.1

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

5.9

13.0

V03AE01

ATC

polystyrene sulfonate; oral

3.5

13.0

127

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.3

13.0

102

460

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

3.1

13.0

167

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

13.0

1466

12453

WX900

NOMESCO Finland

Resuscitation

11.0

13.0

J45

ICD-10 Finland

Asthma

1.7

13.0

262

1620

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.8

13.0

104

AA5PD

NOMESCO Finland

CT examination of brain pefusion

4.2

12.9

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.1

12.9

116

553

Z2445

NOMESCO Finland

Psychologist

2.2

12.8

106

490

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

12.7

136

692

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.0

12.6

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

12.6

390

2668

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

12.5

482

3446

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.0

12.5

187

TFP51

NOMESCO Finland

Ablation treatment of idiopathic left ventricle tachycardia

+∞

12.5

AD1

TVP

+∞

12.5

I36.0

ICD-10 Finland

Nonrheumatic tricuspid (valve) stenosis

+∞

12.5

FA1AC

NOMESCO Finland

Upper cavography

+∞

12.5

4278X

ICD-9 Finland

Cardiac dysrhythmias, Other specified cardiac dysrhythmias[DYSRHYTMIAE CORDIS ALIA DEFINITA]

+∞

12.5

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

12.5

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.3

12.5

392

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

12.5

411

H02AB09

ATC

hydrocortisone; systemic

2.5

12.4

307

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.8

12.4

226

K28

ICPC

Limited function/disability (K)

2.6

12.4

272

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.0

12.4

183

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.3

12.3

142

R03BA02

ATC

budesonide; inhalant

1.5

12.3

458

3255

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

14.4

12.3

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.6

12.2

274

SPAT1254

SPAT

Administration of medicine

1.5

12.2

385

2644

A11

ICPC

Chest pain NOS

1.7

12.2

239

1467

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

12.2

399

5610

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

12.1

274

1743

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

15.9

12.1

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

12.1

436

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.5

12.0

300

N30.0

ICD-10 Finland

Acute cystitis

1.5

12.0

407

2837

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

12.0

188

1084

SPAT1325

SPAT

Vaccination

1.3

12.0

936

7530

5BA08, ,

NOMESCO Finland

5.0

11.9

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.4

11.9

125

M79.6

ICD-10 Finland

Pain in limb

1.3

11.9

1226

10254

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.2

11.8

100

466

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

11.8

452

3226

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.7

11.8

221

N05BA04

ATC

oxazepam; oral

1.4

11.8

706

5452

R05

ICPC

Cough

1.4

11.7

675

5179

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.0

11.7

178

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.7

11.7

228

J01FA06

ATC

roxithromycin; oral

1.3

11.7

1071

8809

SPAT1285

SPAT

Provision of consultation response

1.9

11.7

143

764

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.5

11.7

I44.4

ICD-10 Finland

Left anterior fascicular block

30.1

11.6

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

30.1

11.6

K06.18

ICD-10 Finland

Another gingival hyperplasia

5.5

11.6

R03BA01

ATC

beclometasone; inhalant

1.5

11.6

360

2463

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

65.2

11.6

J01MA02

ATC

ciprofloxacin; systemic

1.3

11.6

1161

9663

SPAT1081

SPAT

Cardiorespiratory global assessment

1.9

11.5

146

788

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.2

11.5

FPE26

NOMESCO Finland

Implantation of permanent biventricular pacemaker, transvenous route

+∞

11.5

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

+∞

11.5

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

+∞

11.5

5244

FHL

Heart transplantation

+∞

11.5

4276A

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA SUPRAVENTRICULARIS]

+∞

11.5

42728

ICD-8 Finland

Symptomatic heart disease, Dissociatio cordis alia

+∞

11.5

K90

ICPC

Stroke/cerebrovascular accident

2.2

11.4

414

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

120.4

11.4

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

120.4

11.4

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

11.4

106

513

J96.1

ICD-10 Finland

Chronic respiratory failure

2.7

11.4

220

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.3

11.3

129

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

11.3

130

679

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

11.3

444

3185

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.1

11.3

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

11.2

102

490

K22

ICPC

Risk factor cardiovascular disease

1.8

11.2

174

1002

SPAT1229

SPAT

Assessment of need for aid

1.7

11.2

207

1252

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

11.1

301

1998

I45.0

ICD-10 Finland

Right fascicular block

8.0

11.1

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

11.0

765

6038

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

11.0

155

866

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.7

11.0

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

9.2

11.0

EB1WA, ,

NOMESCO Finland

4.4

11.0

Q21.10

ICD-10 Finland

Persistent ostium secundum

13.9

11.0

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.5

10.9

I20.9

ICD-10 Finland

Angina pectoris, unspecified

3.3

10.9

127

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.6

10.9

248

Z31.5

ICD-10 Finland

Genetic counselling

1.9

10.8

126

663

3A422, ,

NOMESCO Finland

28.1

10.7

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

10.6

407

AB1

AVR mechanical

60.2

10.6

C02EA02, ,

ATC

2.0

10.6

116

597

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.2

10.5

130

XG405

NOMESCO Finland

Education on PEF monitoring

2.8

10.5

178

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.7

10.5

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

10.5

104

516

SPAT1281

SPAT

Other administrative function

1.7

10.5

205

1258

D07AB08

ATC

desonide; topical

1.6

10.4

279

1847

TK830

NOMESCO Finland

Ultrafiltration

110.4

10.4

I34

ICD-10 Finland

Nonrheumatic mitral valve disorders

110.4

10.4

4229X

ICD-9 Finland

Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA NUD]

+∞

10.4

I40.8

ICD-10 Finland

Other acute myocarditis

+∞

10.4

T86.2

ICD-10 Finland

Heart transplant failure and rejection

+∞

10.4

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

10.4

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

+∞

10.4

4260A

ICD-9 Finland

Conduction disorders, Atrioventricular block, complete

+∞

10.4

TFP45

NOMESCO Finland

Ablation treatment of non-typical atrial flutter

+∞

10.4

XF620

NOMESCO Finland

Examination of circulation with color method

7.7

10.4

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.2

10.3

E85.9

ICD-10 Finland

Amyloidosis, unspecified

12.1

10.3

I27.0

ICD-10 Finland

Primary pulmonary hypertension

32.6

10.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

10.3

261

1707

R03BA05

ATC

fluticasone; inhalant

1.4

10.3

445

3247

SPAT1262

SPAT

Handing over of treatment supplies

1.4

10.3

497

3699

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

4.4

10.3

I45.8

ICD-10 Finland

Other specified conduction disorders

18.8

10.3

R07.2

ICD-10 Finland

Precordial pain

2.5

10.2

256

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.8

10.2

-69

ICPC

Other reason for encounter NEC

2.1

10.2

100

495

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

5.0

10.0

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

10.0

121

644

R03BA08

ATC

ciclesonide; inhalant

1.6

10.0

211

1320

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.5

10.0

235

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

10.0

471

WW500

NOMESCO Finland

Blood transfusion

1.9

10.0

115

602

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.4

10.0

104

UJF92

NOMESCO Finland

Capsular endoscopy

2.6

10.0

212

J46

ICD-10 Finland

Status asthmaticus

2.4

10.0

290

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

40.2

10.0

3A560, ,

NOMESCO Finland

40.2

10.0

W19

ICD-10 Finland

Unspecified fall

1.5

9.9

269

1786

A02BC01

ATC

omeprazole; systemic

1.3

9.9

734

5837

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.4

9.9

291

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.4

9.9

100

E66.0

ICD-10 Finland

Obesity due to excess calories

3.9

9.8

ZYC03

NOMESCO Finland

Remote contact, text-based

4.5

9.8

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

9.8

350

41299

ICD-8 Finland

Chronic ischaemic heart disease, Without mention of hypertensive disease

9.5

9.7

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

9.7

213

1347

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

9.7

351

N03AX16

ATC

[U] pregabalin

1.3

9.7

619

4817

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

55.2

9.6

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

9.6

154

896

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

9.6

357

2533

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

9.6

523

3970

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

9.5

193

1196

M04AA03

ATC

febuxostat; oral

9.1

9.5

4029A

ICD-9 Finland

Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]

10.0

9.5

G71.08

ICD-10 Finland

Other muscular dystrophy

15.1

9.5

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.6

9.5

206

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.5

9.4

218

5401

FHL

Pacemaker installation, transvenous electrode

100.3

9.4

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

9.4

105

545

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

9.4

ASX

Other pacemaker insertion

+∞

9.4

5403

FHL

Replacing the pacemaker

+∞

9.4

4263A

ICD-9 Finland

Conduction disorders, Other left bundle branch block

+∞

9.4

ATB

Replacement of biventricular, physiological pacemaker DDD (R) S

+∞

9.4

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

+∞

9.4

Z94.3

ICD-10 Finland

Heart and lungs transplant status

+∞

9.4

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

+∞

9.4

TFP43

NOMESCO Finland

Ablation treatment for atrial tachycardia

+∞

9.4

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.1

9.3

119

R4130

NOMESCO Finland

Speech therapy

2.2

9.3

371

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

9.2

527

4026

R4150

NOMESCO Finland

Neuropsychological rehabilitation

3.7

9.1

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.6

9.1

193

G72.9

ICD-10 Finland

Myopathy, unspecified

3.5

9.1

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.6

9.1

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

15.6

9.0

K76.1

ICD-10 Finland

Chronic passive congestion of liver

36.8

9.0

474, ,

NOMESCO Finland

36.8

9.0

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.6

8.9

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.6

8.9

R31

ICD-10 Finland

Unspecified haematuria

1.5

8.9

296

2053

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

4.3

8.9

R03DA04

ATC

theophylline; systemic, rectal

1.8

8.8

131

745

SPAT1211

SPAT

Application of soft bandage

1.6

8.8

221

1442

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

8.8

540

4173

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.1

8.7

393

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

8.7

180

1121

N05CD07

ATC

temazepam; oral

1.5

8.7

318

2246

B01AB10

ATC

tinzaparin; parenteral

1.5

8.7

305

2137

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3032080) INR in Blood by Coagulation assay

2351

12114

4.05

319.29

39.0

6.0

1.59

1.09

inr

192.13

2037

9795

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1405

4864

4.22

307.65

8.0

2.9

832.75

509.36

ng/l

0.48

1326

3778

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1074

1573

9.52

307.65

5.1

1.9

363.81

84.21

ng/l

36.23

1044

1394

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1396

3564

5.95

307.65

3.8

2.3

22.96

23.96

1.72

1344

3291

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1425

3896

5.58

307.65

3.8

2.3

2.29

g/l

0.11

1359

3564

(3022948) Iron [Moles/volume] in Serum or Plasma

1455

4209

5.29

307.65

3.8

2.3

13.28

13.54

umol/l

0.56

1394

3887

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2508

6659

11.54

307.65

8.7

1.9

2423.89

530.07

ng/l

49.03

2377

5393

(3027456) Digoxin [Moles/volume] in Serum or Plasma

319

100.48

307.65

3.1

1.7

0.82

0.98

nmol/l

—

245

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1253

4377

3.95

303.07

6.9

3.5

0.82

0.81

mmol/l

0.19

1202

4101

(3020779) Urea [Moles/volume] in Serum or Plasma

828

2288

4.46

274.10

16.5

6.2

11.95

8.93

mmol/l

19.62

800

2187

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

384

592

7.19

241.81

5.2

2.6

0.35

0.34

iu/ml

0.09

233

298

(3000991) Gas panel - Venous blood

757

2236

4.07

225.52

15.1

7.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

370

602

6.77

220.95

3.7

1.7

12.30

11.57

mg/l

0.87

351

554

(3014111) Lactate [Moles/volume] in Serum or Plasma

743

2307

3.84

204.59

13.6

6.6

1.51

1.30

mmol/l

3.15

726

2262

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1462

6887

2.97

201.52

3.0

2.1

2.83

2.67

mg/l

1.63

1303

5801

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

634

1841

4.00

191.28

3.6

1.9

19.56

6.17

ug/l

6.17

580

1575

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1817

9903

2.79

185.73

7.0

2.8

56.60

94.28

ng/l

0.39

1516

7033

(3003458) Phosphate [Moles/volume] in Serum or Plasma

918

3454

3.27

185.61

8.8

5.4

1.09

1.01

mmol/l

13.52

874

3211

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

532

1409

4.29

181.54

5.7

3.5

24.01

24.18

mmol/l

0.56

527

1394

(3018677) aPTT in Platelet poor plasma by Coagulation assay

961

3837

3.10

174.25

4.9

1.9

31.53

28.92

25.76

943

3742

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2000

11756

2.70

171.02

4.6

2.7

174.54

152.09

ug/l

0.92

1911

10831

(3003396) Base excess in Arterial blood by calculation

810

2962

3.28

170.20

13.4

6.9

0.41

0.86

mmol/l

1.84

701

2410

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

445

1079

4.59

169.79

3.6

1.6

34.79

39.74

u/l

4.26

346

967

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

816

3003

3.26

169.60

13.4

6.9

4.97

5.10

kpa

2.89

787

2894

(3019977) pH of Arterial blood

814

2994

3.26

169.31

13.4

6.9

7.42

0.17

367

1645

(3027801) Oxygen [Partial pressure] in Arterial blood

814

3003

3.25

168.37

13.4

6.8

11.49

12.87

kpa

12.35

784

2896

(3021447) Carbon dioxide [Partial pressure] in Venous blood

727

2549

3.36

163.07

5.6

3.2

5.91

5.76

kpa

3.37

714

2488

(3002032) Base excess in Venous blood by calculation

714

2477

3.38

162.92

5.7

3.2

1.78

1.79

mmol/l

0.04

640

2136

(3012544) pH of Venous blood

729

2568

3.34

162.21

5.7

3.2

7.37

7.38

4.46

412

1484

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

529

1510

3.96

162.01

16.3

8.5

24.10

24.25

mmol/l

0.39

512

1490

(3016502) Oxygen saturation in Arterial blood

743

2656

3.30

161.32

14.2

7.3

94.95

96.10

3.91

732

2569

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

796

3029

3.13

154.94

2.3

1.7

—

(3023368) Bacteria identified in Blood by Culture

1480

7780

2.60

154.87

6.3

3.9

—

(3018418) pH of Serum or Plasma

1584

8659

2.55

151.84

6.3

3.9

7.39

7.40

4.29

1212

6068

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2075

12926

2.55

149.26

12.1

5.7

1.19

1.21

mmol/l

30.84

1995

11853

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

995

4364

2.81

148.81

2.3

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

462

1280

4.02

146.88

4.2

3.5

4.22

4.55

pmol/l

7.37

429

1135

(3033658) Prothrombin time (PT) actual/Normal

1390

7259

2.55

145.31

6.6

3.9

74.06

92.89

97.65

1363

7120

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

814

3260

2.97

143.64

2.2

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

427

1150

4.10

140.95

1.9

1.6

1.62

1.58

g/l

0.33

383

987

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

776

3117

2.93

135.39

8.2

4.7

264.12

239.31

u/l

2.94

743

2945

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2231

14837

2.46

131.99

10.3

6.9

14.10

11.93

umol/l

10.89

2167

14151

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2185

14549

2.40

126.47

12.8

6.4

1.20

1.22

mmol/l

32.95

1950

12547

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

300

682

4.73

122.91

4.9

2.4

3.45

3.57

g/l

0.64

286

656

(3013826) Glucose [Moles/volume] in Serum or Plasma

2374

16526

2.45

122.16

10.2

4.3

6.88

6.75

mmol/l

2.22

2307

15638

(3021589) Normoblasts [#/volume] in Blood

1948

12522

2.30

119.78

16.4

10.5

0.00

e9/l

0.03

1593

10151

(3001604) Monocytes [#/volume] in Blood

2117

14122

2.32

118.68

9.7

6.1

0.63

0.60

e9/l

3.59

1839

11934

(3036489) Thrombin time

348

914

4.13

118.21

4.5

1.9

21.95

20.74

1.72

325

821

(3006315) Basophils [#/volume] in Blood

2117

14174

2.31

116.87

9.7

6.2

0.04

e9/l

1.61

1836

11995

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

342

903

4.10

115.26

4.1

2.0

923.92

614.20

ug/l

0.30

334

858

(3019069) Monocytes/Leukocytes in Blood

1988

13024

2.27

114.86

10.0

6.5

9.18

9.03

1.41

1910

12121

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

290

677

4.59

114.81

5.4

2.4

214.21

194.77

2.67

285

645

(3024354) Oxygen [Partial pressure] in Venous blood

573

2126

3.04

113.74

4.7

2.8

4.54

4.50

kpa

0.13

558

2071

(3019198) Lymphocytes [#/volume] in Blood

2136

14453

2.29

113.50

9.7

6.2

1.74

1.94

e9/l

4.57

1892

12531

(42870588) Differential panel, method unspecified - Blood

1577

9445

2.25

113.01

9.3

6.2

—

(3006504) Eosinophils/Leukocytes in Blood

1980

13003

2.25

112.98

9.9

6.4

2.68

2.94

5.74

1902

12094

(3013115) Eosinophils [#/volume] in Blood

2144

14612

2.26

110.73

10.3

6.4

0.18

0.20

e9/l

3.78

1895

12553

(3022096) Basophils/Leukocytes in Blood

1971

13010

2.23

109.82

9.9

6.5

0.65

0.68

2.03

1894

12091

(3002030) Lymphocytes/Leukocytes in Blood

1999

13325

2.21

107.91

9.9

6.4

24.68

27.83

31.53

1930

12532

(3018010) Neutrophils/Leukocytes in Blood

1966

13069

2.20

106.19

9.8

6.3

60.13

56.99

26.97

1911

12406

(36304419) Bacteria [Presence] in Urine

1359

7823

2.23

105.49

4.0

3.1

0.00

estimate

—

(3030467) Casts [#/volume] in Urine by Automated count

1405

8252

2.20

103.14

4.2

3.2

0.81

0.40

e6/l

3.46

1055

5969

(3027945) Reticulocytes/Erythrocytes in Blood

716

3144

2.62

102.33

2.5

1.89

1.69

5.83

655

2764

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1049

5536

2.29

99.43

4.7

1.6

1.48

1.36

mg/l

0.41

834

4353

(3020630) Protein [Mass/volume] in Serum or Plasma

583

2341

2.80

99.19

2.5

2.7

64.76

66.93

g/l

8.56

542

2116

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1430

8588

2.15

97.83

3.0

2.1

366.05

209.45

u/l

0.83

1369

8085

(3013650) Neutrophils [#/volume] in Blood by Automated count

2239

15981

2.17

96.71

12.6

10.0

4.35

4.13

e9/l

4.51

1954

13745

(3052851) Hemolysis interference index of Serum or Plasma

276

708

4.15

96.34

4.9

3.2

2.37

2.13

index

0.26

163

355

(3044889) 12 lead EKG panel

2603

19818

2.34

94.57

8.3

3.4

4103.60

0.44

—

(3002582) Erythrocytes [#/volume] in Urine

1524

9556

2.08

91.21

4.3

3.3

73.31

91.55

e6/l

0.33

1175

7248

(3026250) Tacrolimus [Mass/volume] in Blood

102

104

10.08

89.27

42.5

36.4

7.64

7.26

ug/l

0.59

(3042936) Bacteria identified in Isolate by Culture

786

3828

2.37

88.44

2.7

1.9

—

(3024928) Oxygen saturation in Venous blood

235

575

4.32

87.20

4.7

2.7

62.04

60.27

0.52

230

557

(3024561) Albumin [Mass/volume] in Serum or Plasma

1901

13056

2.03

87.01

6.7

5.0

34.39

35.72

g/l

19.08

1806

12170

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

436

1611

2.96

85.86

2.0

1.6

—

(3042733) HLA Ab [Presence] in Serum

12.43

85.78

4.7

4.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1241

7383

2.07

83.91

3.7

2.6

389.18

342.55

umol/l

31.31

1091

6488

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

686

3217

2.42

83.58

3.1

2.9

9.06

9.29

umol/l

0.11

627

2845

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

959

5195

2.18

82.76

3.6

3.0

1.14

1.06

e6/l

0.21

518

2751

(3018095) Leukocytes [#/volume] in Urine

1622

10694

1.99

81.50

5.1

3.9

62.12

95.78

e6/l

2.27

1196

7528

(40758558) Short blood count panel - Blood

1388

8671

2.02

81.34

9.8

6.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

104

9.27

77.42

30.3

25.8

115.36

118.12

ug/l

0.12

(3003434) Protein [Mass/volume] in Pleural fluid

145

268

5.61

74.95

1.6

1.3

28.45

37.39

g/l

10.27

120

257

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

883

4804

2.13

74.15

3.8

3.1

2.53

2.09

e6/l

0.70

438

2359

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

172

374

4.79

73.89

1.5

1.2

2.54

u/ml

0.00

110

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

171

371

4.80

73.65

1.5

1.2

2.94

3.12

u/ml

0.12

161

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

277

870

3.38

71.45

2.3

0.01

0.05

g/l

0.90

253

783

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

183

433

4.41

70.75

1.5

156.54

153.98

au/ml

0.10

128

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

455

1895

2.62

70.57

1.7

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

214

573

3.92

70.07

2.5

2.9

33.12

37.14

umol/l

1.05

197

514

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

195

488

4.18

70.05

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

195

488

4.18

70.05

1.4

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

256

775

3.49

69.93

2.3

2.4

0.00

g/l

-0.00

239

729

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

206

541

3.99

69.29

9.9

5.4

247.72

3458.03

iu/ml

0.58

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

580

2735

2.35

68.62

2.7

2.5

44.02

59.73

u/l

0.42

492

2350

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1408

9225

1.90

68.45

3.7

3.4

44.06

36.46

u/l

1.25

1339

8646

(3023520) Reticulocytes [#/volume] in Blood

533

2430

2.42

68.03

2.5

73.33

66.27

e9/l

3.38

344

1779

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

191

481

4.15

68.02

1.6

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

265

842

3.33

67.02

2.3

0.00

g/l

0.14

239

731

(3023199) Leukocytes [#/volume] in Pleural fluid

130

250

5.37

64.31

1.6

1.3

8744.36

6009.66

e6/l

0.12

172

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

182

462

4.11

64.09

1.5

1.3

291.83

251.75

u/ml

0.99

131

286

(3000850) Epithelial cells [#/volume] in Urine

1067

6513

1.93

63.25

3.2

2.6

5.08

4.56

e6/l

0.74

982

5884

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

309

1116

2.95

62.71

2.3

3.05

2.86

g/l

2.86

291

996

(3045788) Cell count panel - Pleural fluid

114

200

5.86

62.23

1.6

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

249

799

3.28

61.88

3.1

3.3

1.51

7.01

ratio

0.72

140

466

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

566

2753

2.27

61.77

2.3

0.20

0.21

g/l

3.95

534

2586

(3004119) Hemoglobin [Mass/volume] in Venous blood

387

1591

2.62

61.23

5.0

2.7

128.25

129.70

g/l

0.56

381

1545

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

319

1188

2.86

61.17

2.3

3.65

3.78

g/l

0.80

301

1068

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

319

1189

2.86

61.07

2.3

7.31

7.44

g/l

0.57

301

1068

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

319

1189

2.86

61.07

2.3

4.07

4.24

g/l

3.81

301

1069

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2693

22133

2.04

61.05

13.1

8.1

83.04

80.72

u/l

1.24

2610

20900

(3034860) Kappa light chains.free [Mass/volume] in Serum

269

912

3.12

60.97

3.1

3.4

50.73

100.48

mg/l

0.41

237

797

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

268

909

3.12

60.69

3.1

3.4

44.14

54.72

mg/l

0.37

236

795

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

290

1036

2.97

59.96

2.3

10.07

10.25

g/l

0.28

271

903

(3028308) Erythrocytes [#/volume] in Pleural fluid

120

229

5.40

59.86

1.6

1.3

29626.87

82948.51

e6/l

1.23

127

(3017143) Hepatitis C virus Ab [Presence] in Serum

544

2655

2.25

58.66

1.8

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

185

509

3.79

58.17

1.4

1.3

—

45.28

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

145

334

4.49

57.94

8.4

6.1

10.78

11.64

mg/l

1.28

129

308

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

443

1992

2.41

57.75

5.0

3.6

125.22

81.36

ng/l

12.86

400

1730

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

288

1049

2.91

57.44

2.5

2.3

0.45

1.11

g/l

3.06

259

891

(4195642) Thrombophilia screening test

148

349

4.39

57.40

1.4

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

153

378

4.19

55.83

1.3

1.1

—

(3024932) HLA-DR beta [Type]

9.45

54.58

1.1

—

(3024471) HLA-A [Type]

9.45

54.58

1.0

—

(3044640) Blood type and Crossmatch panel - Blood

1340

9108

1.78

54.29

3.3

2.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

403

1789

2.42

53.88

1.5

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

216

700

3.23

52.70

1.9

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

658

3629

2.01

50.91

1.9

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1071

6919

1.80

50.80

3.2

2.4

—

(4268621) Lupus anticoagulant assay

118

258

4.70

50.28

3.1

2.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

156

423

3.82

50.05

4.1

3.0

765.55

3422.43

u/ml

0.89

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

199

641

3.24

49.00

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

113

244

4.76

48.88

2.5

2.3

26.99

34.29

iu/ml

0.31

(3026782) Osmolality of Urine

906

5620

1.83

48.82

3.4

2.8

519.55

551.35

mosm/kgh2o

5.42

802

4892

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

575

3072

2.05

48.39

1.8

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

207

693

3.12

47.77

1.4

1.3

—

(40768806) Pleura Pathology biopsy report

104

215

4.96

47.37

1.6

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

224

799

2.93

46.23

4.8

3.6

1.83

1.43

mg/l

8.46

207

729

(3031040) Bacteria [#/volume] in Urine by Automated count

2268

18306

1.72

46.03

5.7

4.5

3491.93

1963.96

e6/l

0.35

276

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

208

715

3.03

45.84

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

111

254

4.48

44.71

6.1

3.0

14.08

11.82

index

1.63

136

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

189

630

3.12

43.91

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

248

961

2.71

43.76

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

518

2764

2.03

43.39

4.4

3.2

—

(3037522) Nuclear Ab [Titer] in Serum

617

3506

1.93

43.08

1.4

1.3

504.33

501.92

titre

0.01

120

730

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

132

5.95

43.04

1.3

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2454

20433

1.72

42.37

5.2

4.0

15.30

14.78

pmol/l

16.78

2301

18473

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

165

518

3.30

42.33

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

303

1317

2.43

42.09

1.6

1.4

—

(1616796) Gas panel - Central venous blood

164

521

3.26

41.27

5.9

3.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

116

292

4.08

41.26

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

116

292

4.08

41.26

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

116

292

4.08

41.26

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

116

292

4.08

41.26

1.5

—

(3026008) Bacteria identified in Urine by Culture

1169

8165

1.66

39.63

3.5

3.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

217

4.52

39.27

1.2

112.00

153.90

titre

0.42

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

174

600

3.00

38.09

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

106

271

4.01

36.93

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

161

543

3.06

36.63

1.5

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

448

2410

1.99

36.27

2.5

368.85

378.53

nmol/l

0.42

425

2235

(3011397) Hemoglobin [Presence] in Urine by Test strip

996

6805

1.66

36.09

4.0

3.6

0.17

0.11

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

185

684

2.80

35.65

1.7

1.5

0.24

g/l

0.23

173

648

(3034426) Prothrombin time (PT)

7.32

35.60

1.5

1.2

29.22

27.67

1.10

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

188

706

2.76

35.17

1.6

1.5

1.16

1.22

g/l

1.53

178

665

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

195

4.50

35.06

1.5

1.3

729.93

504.46

u/l

0.16

184

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1677

13053

1.56

34.70

3.7

2.7

—

estimate

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

139

446

3.21

34.41

1.6

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

226

946

2.49

33.94

2.4

2.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

139

451

3.17

33.78

1.4

—

(3012501) Base excess in Blood by calculation

144

478

3.10

33.67

6.5

3.5

2.82

2.33

mmol/l

1.06

103

313

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2625

22760

1.67

33.52

41.1

18.0

14.17

13.60

67.48

2605

22427

(3008152) Bicarbonate [Moles/volume] in Arterial blood

319

1578

2.13

32.30

10.4

6.3

24.20

24.49

mmol/l

0.64

313

1506

(3028026) IgM [Mass/volume] in Serum or Plasma

318

1581

2.12

31.76

2.1

1.9

1.36

1.41

g/l

0.08

297

1446

(3021960) Folate [Moles/volume] in Serum or Plasma

1154

8443

1.56

30.25

1.9

1.6

19.37

20.29

nmol/l

1.41

1027

7048

(3018405) Lactate [Moles/volume] in Arterial blood

195

809

2.50

29.82

6.7

3.7

1.52

1.39

mmol/l

0.70

188

801

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

404

2238

1.91

29.70

3.8

2.6

50.40

68.30

ml/min/173m2

17.21

181

901

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

195

811

2.49

29.66

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

107

321

3.41

29.53

1.4

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

374

2035

1.94

28.98

3.0

2.7

10.06

10.59

g/l

1.63

352

1874

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

153

576

2.73

28.48

1.5

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1199

8979

1.52

27.62

3.2

2.6

62.88

62.37

u/l

0.04

1128

8285

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

231

1084

2.21

26.63

2.2

1.8

1.29

2.14

ug/l

0.88

210

965

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

103

327

3.22

25.99

1.4

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

172

4.13

25.79

1.4

1.2

85.00

85.33

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

154

614

2.58

25.59

1.2

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

136

4.55

25.45

1.2

33.98

23.69

u/l

0.88

109

(3007164) IgA [Mass/volume] in Serum or Plasma

741

5064

1.59

25.38

1.7

1.5

2.62

2.54

g/l

0.46

461

2986

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

112

379

3.02

25.37

1.5

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2990

27406

1.75

24.74

33.1

14.2

25.19

26.51

mg/l

1.57

2707

22173

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

10.07

24.72

1.3

1.1

78.60

114.91

ng/l

0.14

(3035880) pH of Pleural fluid

108

4.97

24.62

1.3

7.38

7.37

0.04

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

125

460

2.78

24.32

1.6

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

133

4.50

24.29

1.2

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

133

4.50

24.29

1.2

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

152

618

2.53

24.26

2.9

2.1

129.81

130.81

g/l

0.16

111

461

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

142

4.36

24.12

1.2

110.54

90.34

u/l

0.68

116

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2387

20849

1.49

23.55

5.9

4.2

14.87

11.79

mm/h

16.26

2259

19379

(21494890) Protein electrophoresis panel - 24 hour Urine

241

3.42

22.70

2.0

2.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2785

25198

1.58

22.69

6.5

4.9

2.04

1.94

mu/l

3.33

2626

22885

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.43

22.12

2.2

2.7

0.63

0.60

mmol/l

1.28

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

293

3.13

21.82

3.6

4.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

7.17

21.61

1.7

1.3

78.45

76.27

0.10

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1618

13296

1.41

21.15

2.4

2.1

90.92

94.84

pmol/l

3.02

896

7002

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

166

3.85

21.14

1.5

1.2

14.88

14.52

u/l

0.02

160

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

273

1482

1.92

21.13

4.4

3.1

2.29

1.57

mmol/l

1.67

199

1065

(3019309) Folate [Moles/volume] in Red Blood Cells

705

4944

1.54

21.06

1.8

1.7

1186.28

1122.38

nmol/l

1.03

563

3667

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

313

1781

1.83

20.91

4.6

3.2

5.12

5.11

kpa

0.06

296

1698

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

7.10

20.77

1.6

1.3

79.84

72.15

0.38

(3015377) Calcium [Moles/volume] in Serum or Plasma

1282

10140

1.42

20.66

3.9

3.7

2.35

2.36

mmol/l

1.37

1154

9160

(3009343) pH of Capillary blood

305

1728

1.84

20.66

4.6

3.2

7.41

7.42

0.58

266

1397

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

256

3.22

20.64

1.5

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

184

874

2.17

20.57

7.3

1.5

5.45

5.20

mg/l

0.07

168

630

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

278

3.11

20.46

1.5

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

130

535

2.49

20.25

1.2

—

(3037756) Immunofixation for Serum or Plasma

132

549

2.46

20.11

1.6

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.57

19.60

1.3

1.0

—

(3003181) Sodium [Moles/volume] in Urine

119

481

2.53

19.27

1.6

1.4

61.30

63.45

mmol/l

0.20

395

(3023420) DNA double strand Ab [Units/volume] in Serum

200

1010

2.04

19.04

1.7

5.97

6.89

iu/ml

0.16

253

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

141

620

2.33

18.99

1.5

1.9

169.34

3.91

iu/l

0.49

239

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

249

3.10

18.28

1.2

63.23

63.92

u/l

0.01

217

(3007566) Smooth muscle Ab [Titer] in Serum

157

746

2.16

17.55

1.2

1.3

180.00

103.43

titre

0.43

(3014765) Yersinia sp identified in Stool by Organism specific culture

148

689

2.20

17.42

1.3

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

5.27

17.01

1.4

1.3

63.16

60.02

0.16

(42529406) Shigella sp [Presence] in Stool by Culture

148

696

2.18

16.99

1.3

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

794

5931

1.44

16.84

2.8

3.3

2.47

2.45

mmol/l

2.32

686

5331

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

108

454

2.42

16.13

5.4

3.0

11.71

8.82

pmol/l

1.62

108

454

(3019550) Sodium [Moles/volume] in Serum or Plasma

3057

28748

1.63

16.08

45.0

16.4

139.27

139.73

mmol/l

17.31

3024

28099

(3020682) Albumin/Creatinine [Ratio] in Urine

1264

10286

1.36

16.03

4.4

4.1

14.14

5.80

mg/mmol

5.36

848

6368

(3012516) Albumin [Mass/volume] in Urine

1246

10119

1.37

15.99

3.8

3.4

76.75

35.96

mg/l

5.04

877

6388

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

144

687

2.14

15.96

1.3

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.42

15.89

1.3

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1291

10560

1.36

15.76

3.8

3.4

6.99

7.90

mmol/l

12.87

1104

8871

(44816559) Phosphatidylethanol [Mass/volume] in Blood

207

1141

1.87

15.27

1.6

1.7

0.37

0.33

mg/l

0.46

554

(3023103) Potassium [Moles/volume] in Serum or Plasma

3058

28819

1.61

15.23

45.6

16.5

4.05

3.98

mmol/l

33.24

3023

28121

(3026692) Albumin [Mass/volume] in Peritoneal fluid

4.58

14.92

1.8

1.3

16.84

11.49

g/l

2.54

(3004451) EKG impression Narrative

112

3.88

14.74

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

103

443

2.37

14.65

1.4

1.6

0.63

0.86

g/l

1.84

357

(3025941) Bacteria identified in Stool by Culture

225

1290

1.80

14.61

1.4

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

212

3.01

14.54

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

212

3.01

14.54

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

212

3.01

14.54

1.6

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

5.21

14.37

1.3

1.2

3.09

2.44

0.15

(3038071) Oxygen [Partial pressure] in Mixed venous blood

6.19

14.19

3.9

6.2

5.99

5.35

kpa

0.58

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

237

2.86

14.16

1.2

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

1711

14768

1.32

13.85

4.4

3.7

0.00

estimate

0.50

363

3066

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

346

2260

1.59

13.77

6.1

3.6

1.21

1.23

mmol/l

7.21

320

1916

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

400

2.39

13.72

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

1726

14928

1.32

13.71

4.5

3.7

8.04

4.11

estimate

0.30

368

3163

(3014051) Protein [Presence] in Urine by Test strip

982

7832

1.36

13.66

3.3

2.9

0.00

0.03

1.28

215

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

148

759

1.99

13.55

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

390

2.40

13.54

1.4

0.36

0.31

nmol/l

0.12

(3010838) Calcium [Moles/time] in 24 hour Urine

101

449

2.29

13.35

1.9

2.0

4.72

4.97

mmol/24h

0.36

387

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

110

507

2.21

13.33

1.1

1.3

35.35

30.52

u/l

0.18

100

426

(1761868) Lipid panel - Serum or Plasma

831

10415

0.73

13.15

3.6

3.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

421

2.32

13.10

1.3

—

22.74

—

(3015736) pH of Urine

1395

11768

1.31

13.04

4.0

3.3

6.26

6.21

0.84

682

6560

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.10

13.01

2.5

1.7

26059.86

2725.13

e6/l

0.60

(3023487) Leukocytes [#/volume] in Peritoneal fluid

104

3.78

12.97

2.9

1.9

579.25

459.29

e6/l

0.44

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

331

2.48

12.92

1.4

0.45

0.19

nmol/l

0.57

261

(3023419) Bacteria identified in Sputum by Culture

368

2.40

12.88

2.1

2.6

—

(3000012) Reticulocyte production index

370

2.39

12.74

2.1

2.0

0.94

0.83

1.03

247

(3020876) Protein [Mass/time] in 24 hour Urine

316

2.50

12.68

2.4

1.67

1.23

g/24h

0.49

174

(3000093) Morphology [Interpretation] in Blood Narrative

248

2.69

12.49

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1726

15043

1.30

12.45

4.5

3.7

0.03

0.01

estimate

0.56

336

2938

(3027135) IgG subclass 1 [Mass/volume] in Serum

260

2.65

12.44

1.3

7.61

6.52

g/l

1.05

197

(3024139) IgG subclass 3 [Mass/volume] in Serum

260

2.65

12.44

1.3

0.46

0.38

g/l

1.05

193

(3028192) IgG subclass 2 [Mass/volume] in Serum

260

2.65

12.44

1.3

2.87

3.07

g/l

0.32

196

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1729

15076

1.30

12.41

2.9

2.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1487

12726

1.30

12.23

2.9

2.3

77.40

78.71

nmol/l

0.96

1353

11354

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

5.13

12.20

1.0

1.1

1100.00

960.00

titre

—

(3042631) Mycobacterium sp identified in Specimen

375

2.33

11.92

1.8

2.8

—

(4062490) Immunoglobulin typing, IgG

255

2.62

11.85

1.4

1.3

—

(3044007) Cell count panel - Peritoneal fluid

3.89

11.81

2.9

1.7

—

(3047189) Immunofixation for 24 hour Urine

116

3.48

11.80

1.6

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

135

713

1.93

11.40

1.5

1.6

11955.79

12305.44

e6/l

0.05

483

(3016650) Hepatitis A virus Ab [Presence] in Serum

425

2.20

11.15

1.2

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2862

26959

1.39

10.78

34.3

14.2

72.76

79.68

ml/min/173m2

48.77

2771

24863

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

10.42

2.0

0.0

0.82

—

ug/l

—

(40768797) Stomach Pathology biopsy report

523

3934

1.39

10.13

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

177

1057

1.71

10.03

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.05

9.95

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

160

2643

0.59

9.93

1.8

2.1

3.72

3.60

ratio

0.52

124

2120

(3000494) Fungus identified in Specimen by Culture

465

3440

1.41

9.93

1.8

1.5

—

(3014891) Appearance of Pleural fluid

12.20

9.84

1.9

1.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

26.08

9.80

2.7

4.4

110.46

99.20

g/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

181

2.73

9.66

2.1

2.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

735

5877

1.32

9.50

6.9

4.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2820

26625

1.35

9.45

7.6

6.5

41.13

39.43

mmol/mol

16.83

2680

24685

(3017569) Oxygen content in Arterial blood

150

2.89

9.43

2.5

2.1

16.27

16.87

0.42

150

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.90

9.13

1.2

1.3

61.79

85.06

2.31

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

132

2.98

9.03

2.4

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2012

18257

1.25

8.96

4.1

3.2

70.52

50.87

u/l

9.74

1895

16965

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

252

3651

0.67

8.76

5.2

5.1

32.04

32.23

0.10

195

2257

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

322

2.20

8.65

1.3

1.4

—

nmol/l

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

7.64

8.63

1.3

15.90

8.27

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

118

658

1.82

8.51

2.2

2.3

104.35

99.89

ug/min

0.05

388

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

721

5835

1.30

8.41

1.3

1.97

1.72

u/ml

0.12

178

1498

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

454

1.99

8.40

1.2

1.1

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

4.31

8.39

1.7

1.2

20.33

23.38

0.19

(21494755) Public health laboratory ask at order entry panel

130

2166

0.58

8.34

1.2

1.4

—

(40761536) Microorganisms panel - Urine sediment

301

2127

1.46

8.24

4.7

3.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

144

862

1.70

8.14

1.6

—

(3035933) Granulocytes/Leukocytes in Blood

101

544

1.88

8.14

3.6

3.3

60.99

57.74

1.59

101

544

(3042111) Morphology [Interpretation] in Bone marrow Narrative

469

1.94

8.01

1.8

1.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.64

8.00

1.2

1.3

61.73

90.55

2.06

(4035726) Immunohistochemistry procedure

370

2730

1.40

7.97

2.1

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

480

1.92

7.82

1.2

240.00

279.57

titre

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2463

23014

1.25

7.80

45.0

18.7

329.79

333.02

g/l

55.36

2447

22877

(3015171) Extractable nuclear Ab [Units/volume] in Serum

152

938

1.65

7.68

1.3

1.2

0.45

1.21

u/ml

0.75

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

192

2.47

7.65

1.3

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

186

2.49

7.65

1.3

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

424

3221

1.36

7.64

1.8

1.60

1.52

1.17

352

2823

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

226

2.32

7.40

1.5

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

115

1912

0.59

7.33

1.6

1.8

3.35

3.51

mmol/l

0.73

1361

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

190

2.44

7.33

1.3

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.10

7.28

1.2

1.1

281.38

193.69

iu/ml

0.32

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

197

2.41

7.26

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

197

2.41

7.26

1.3

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.56

7.14

1.3

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

205

2.36

7.12

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

554

1.81

7.11

1.2

1.3

268.51

216.52

miu/ml

0.47

229

(40759836) Histone Ab [Presence] in Serum by Immunoblot

199

2.38

7.11

1.3

1.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

7.92

7.09

1.5

1.1

77.21

77.26

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

6.03

7.06

1.4

1.1

91.89

101.63

0.43

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

170

2.49

7.00

1.3

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

297

2.11

7.00

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

183

2.42

6.92

1.3

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

10.94

6.79

2.3

3.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

167

2.47

6.75

1.3

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

441

1.88

6.70

1.2

—

0.90

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

144

2.59

6.69

1.8

1.5

2.82

7.37

u/l

2.24

120

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

205

2.31

6.67

1.3

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2737

26030

1.26

6.65

5.1

4.3

1.39

1.31

mmol/l

5.93

2572

23581

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

195

2.33

6.49

1.2

1.1

97.44

109.50

pmol/l

1.06

195

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

512

1.80

6.46

1.4

1.2

64.29

34.47

u/ml

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.93

6.43

1.3

1.1

1.45

2.13

mmol/l

1.17

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

165

2.44

6.43

1.6

1.4

5.60

5.80

u/l

0.12

141

(21494434) Karyotype in Bone marrow

241

2.18

6.41

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

184

2.35

6.38

1.9

2.3

13.95

15.08

0.27

177

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

229

2.20

6.34

1.4

1.1

—

(3028433) Virus identified in Specimen by Culture

3.04

6.34

1.0

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

2.95

6.26

1.9

2.5

26.96

29.39

0.35

(3048689) Calprotectin [Mass/mass] in Stool

421

3292

1.32

6.22

2.1

2.5

139.17

153.80

ug/g

0.34

343

2626

(3003694) ABO and Rh group [Type] in Blood

910

7818

1.22

6.10

1.4

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

342

2603

1.35

6.08

5.8

4.5

0.70

1.01

2.43

130

769

(3000570) Elastase.pancreatic [Mass/mass] in Stool

138

886

1.58

6.01

1.3

1.4

319.76

264.95

ug/g

0.60

515

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

583

4784

1.26

5.92

1.3

31.61

36.92

iu/ml

0.48

181

1415

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.69

5.91

1.0

1.3

0.85

0.66

umol/24h

—

(3002179) Metamyelocytes/Leukocytes in Blood

325

2475

1.35

5.76

5.6

4.3

0.63

0.72

0.26

123

718

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

130

836

1.58

5.64

1.5

0.08

4.44

iu/ml

0.51

143

(3022313) Gas panel - Capillary blood

183

1267

1.47

5.63

4.6

3.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.20

5.59

1.6

1.5

10.68

8.55

ug/l

0.85

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

310

1.95

5.59

1.3

1.86

1.39

nmol/l

1.70

278

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

4.61

5.47

1.1

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

143

947

1.53

5.46

1.7

1.6

13.97

19.11

u/ml

0.68

200

(3008536) Aspergillus sp Ab [Presence] in Serum

3.35

5.44

1.7

2.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

16.04

5.41

2.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.10

5.33

1.3

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

155

2.34

5.33

2.5

2.9

42.95

37.48

0.77

(3040151) Glucose [Moles/volume] in Capillary blood

282

1.97

5.25

10.6

6.7

6.92

7.33

mmol/l

0.49

229

(3011412) CD3 cells [#/volume] in Blood

241

2.05

5.25

2.5

946.16

1199.45

e6/l

1.58

212

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.59

5.17

1.4

1.1

0.52

2.66

mmol/l

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

217

2.09

5.09

2.0

2.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

204

2.12

5.07

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

200

1438

1.42

5.06

1.5

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

344

1.85

5.01

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

179

2.19

4.99

1.1

1.0

—

0.62

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

148

2.31

4.93

1.0

1.2

—

(3021440) Promyelocytes/Leukocytes in Blood

320

2491

1.31

4.89

5.9

4.5

0.07

0.14

1.69

108

662

(3007930) Methemoglobin/Hemoglobin.total in Blood

163

1136

1.46

4.89

6.4

4.8

0.79

0.88

3.11

158

1072

(3049717) Cytology report of Urine Cyto stain

173

1227

1.43

4.74

2.6

3.0

—

(3006245) CD3-CD19+ cells/cells in Blood

2.62

4.72

2.1

2.7

10.04

11.51

0.14

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

219

2.02

4.61

1.3

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3063

29783

1.29

4.59

45.5

18.8

94.25

78.27

umol/l

58.48

3029

29363

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

134

2.33

4.59

2.8

2.1

120.33

240.41

ug/min

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

835

0.52

4.58

1.1

0.60

0.64

ratio

—

105

(3046861) Legionella sp Ag [Presence] in Urine

8.20

4.56

1.1

1.0

—

(3025159) Blasts/Leukocytes in Blood

319

2510

1.30

4.52

6.0

4.7

0.64

0.33

0.21

104

619

(3002619) Bacteria identified in Specimen by Culture

3.16

4.48

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

533

4463

1.23

4.46

1.2

1.3

14.03

12.76

u/ml

0.14

185

1659

(3022145) Colonoscopy Study observation

412

3354

1.26

4.44

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

307

1.84

4.44

1.5

65.03

55.37

0.99

184

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.01

4.39

1.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

170

2.13

4.34

2.5

0.61

0.69

e9/l

0.35

165

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

142

988

1.46

4.34

4.5

3.2

24.52

24.70

mmol/l

0.26

133

899

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

144

2.23

4.33

1.3

1.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

276

2142

1.31

4.33

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

116

776

1.51

4.30

7.1

5.9

1.33

1.31

mmol/l

0.09

106

686

(3025130) Human papilloma virus identified in Specimen

255

1.89

4.21

1.9

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.67

4.15

1.1

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

109

2.40

4.14

1.2

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

101

662

1.54

4.13

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

202

1509

1.36

4.12

1.1

1.2

181.71

132.88

u/ml

0.60

540

(3017315) Amylase [Enzymatic activity/volume] in Urine

122

2.31

4.10

1.3

1.2

239.93

461.50

u/l

0.89

116

(3000330) Specific gravity of Urine by Test strip

194

1444

1.36

4.05

3.4

3.2

1.02

ratio

2.28

173

1311

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

123

2.29

4.03

1.3

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.68

3.98

1.2

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.43

3.96

1.9

2.1

—

(3037121) Protein [Mass/volume] in Urine

132

924

1.45

3.94

2.9

3.7

323.22

338.45

mg/l

0.06

433

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

157

2.11

3.93

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

144

2.16

3.92

2.4

1.9

8.34

7.77

mmol/l

0.31

144

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

166

2.06

3.80

2.6

2.7

422.84

585.76

e6/l

1.06

134

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.83

3.69

1.5

1.7

—

(36660697) Celiac disease serology panel - Serum

261

2058

1.29

3.68

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

365

1.68

3.65

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

708

0.55

3.59

1.8

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

7.79

3.56

4.0

3.9

—

(3008295) Osmolality of Serum or Plasma

300

1.74

3.55

1.7

1.4

273.21

279.92

mosm/kgh2o

1.13

226

(3045142) Bone marrow Pathology biopsy report

346

1.69

3.52

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

210

1619

1.32

3.51

1.5

1.3

255.05

264.50

u/ml

0.06

202

1498

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

228

1778

1.30

3.50

1.3

24.69

64.40

au/ml

4.91

128

(4034850) Laboratory test

122

862

1.43

3.50

18.9

8.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

142

1031

1.39

3.49

2.1

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

115

2.18

3.28

1.7

2.7

46.91

155.25

umol/l

2.21

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.58

3.26

3.3

6.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

111

782

1.43

3.26

1.3

—

(3002256) Pathology report gross observation

473

4038

1.20

3.25

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

170

1.95

3.23

2.2

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

220

1.83

3.23

2.3

2.6

37.84

31.61

mg/l

0.33

156

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

150

2.01

3.19

1.1

1.5

—

(40768804) Tissue Pathology biopsy report

1250

11515

1.14

3.14

2.3

2.2

—

(40768443) Skin Pathology biopsy report

171

1303

1.33

3.13

1.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.23

3.05

2.0

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.23

3.05

2.0

2.1

—

(3000060) B lymphocytes [#/volume] in Blood

2.44

3.04

1.9

2.4

0.16

0.54

e9/l

0.50

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

958

10519

0.88

3.03

3.7

4.7

22.89

21.85

1.07

411

5400

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3011

29418

1.21

3.02

19.3

11.8

27.72

26.87

u/l

1.25

2945

28431

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.56

2.99

1.5

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

10.01

2.98

9.6

5.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

301

2483

1.23

2.94

2.7

2.4

0.75

0.42

e6/l

1.42

289

2381

(3001019) Free T4 and TSH panel - Serum or Plasma

1055

0.67

2.94

1.8

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

161

1230

1.32

2.92

2.5

3.9

403.55

2334.35

u/ml

1.20

139

1076

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

367

1.59

2.86

1.2

1.3

341.48

269.50

pmol/l

0.77

308

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

130

2.01

2.80

3.2

4.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

270

3271

0.81

2.80

2.4

2.3

13.41

13.59

nmol/l

0.12

237

2985

(1617658) Protocol used for examination of sentinel lymph nodes

205

0.34

2.78

1.1

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.92

2.77

1.0

1.5

2.19

1.77

umol/24h

—

(40768446) Kidney Pathology biopsy report

2.17

2.76

2.2

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2878

28051

1.17

2.75

6.8

5.9

2.44

2.72

mmol/l

54.56

2735

25833

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

885

0.65

2.75

1.2

1.47

1.50

g/l

0.38

885

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

438

3772

1.19

2.74

1.5

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

161

1244

1.31

2.71

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.71

1.4

1.2

1.15

1.17

mmol/l

0.51

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

238

1933

1.25

2.69

2.4

2.5

12.80

22.11

au/ml

2.68

184

(3044927) Protein electrophoresis panel - Urine

264

1.68

2.69

1.3

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

694

1.41

2.68

1.4

1.2

7.43

2.01

u/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

335

1.59

2.65

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

126

1.99

2.65

1.2

1.1

—

(3024263) Appearance of Synovial fluid

147

1.91

2.65

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

133

1.96

2.65

1.9

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

133

1.96

2.65

1.9

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

133

1.96

2.65

1.9

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

133

1.96

2.65

1.9

1.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.13

2.64

1.7

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

696

1.41

2.64

1.4

1.2

5.00

7.87

u/ml

0.48

106

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

201

1605

1.27

2.64

1.7

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

297

1.62

2.62

1.1

1.2

—

(3017704) Immunofixation for Urine

141

1.92

2.60

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

100

2.11

2.58

1.1

1.3

148.95

182.42

mmol/24h

1.12

100

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.01

2.56

1.1

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

7.15

2.55

1.0

282.40

284.86

nmol/l

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.46

2.54

1.5

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

925

0.68

2.50

1.3

1.2

0.93

0.90

g/l

0.46

925

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2779

27070

1.15

2.44

5.9

5.3

6.23

6.00

mmol/l

13.89

2582

24665

(3018133) Calcium [Moles/volume] in Urine

2.55

2.44

2.7

2.0

2.17

2.70

mmol/l

0.60

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

3.13

2.43

5.0

6.6

10.75

10.80

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

127

966

1.33

2.43

1.8

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

183

1462

1.27

2.42

2.6

2.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

167

1.80

2.40

2.8

183.80

243.01

e6/l

1.32

141

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.01

2.40

2.7

2.2

—

(3045424) Erythrocytes [Presence] in Urine

110

1447

0.75

2.29

2.6

2.2

0.00

0.01

estimate

0.88

464

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.48

2.27

1.1

1.0

124.00

82.09

titre

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.07

2.27

1.4

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2804

27363

1.14

2.26

5.8

5.0

1.33

1.45

mmol/l

43.76

2654

25110

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2822

27558

1.14

2.22

5.9

5.1

4.26

4.64

mmol/l

70.93

2680

25473

(3014271) Vancomycin [Susceptibility]

121

1.91

2.20

4.3

2.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

338

1.52

2.14

3.3

3.7

4.77

20.70

nmol/l

0.49

331

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

204

1.67

2.14

1.2

1.3

—

93.85

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.78

2.13

1.2

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

212

1750

1.23

2.12

1.9

2.0

—

(3017732) Neutrophils [#/volume] in Blood

405

3545

1.16

2.10

3.4

5.22

4.73

e9/l

0.30

362

3011

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.50

2.05

2.0

3.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.98

2.05

1.2

1.9

2.49

6.77

ug/l

0.75

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

238

1.60

2.04

1.7

1.5

45.80

26.27

u/ml

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.40

2.02

1.8

3.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

516

0.62

2.02

1.6

1.5

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

247

1.59

2.01

1.6

1.5

24.49

31.18

0.58

142

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

248

1.58

1.98

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

217

1.62

1.97

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.34

1.96

1.1

1.5

—

(3034891) Synovial lining cells/cells in Synovial fluid

134

1.80

1.95

1.5

1.4

4.00

4.38

0.06

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

382

3353

1.16

1.93

3.0

4.8

7.03

22.98

ug/l

3.12

312

2786

(3019420) Tryptase [Mass/volume] in Serum or Plasma

150

1.74

1.90

2.0

1.3

11.29

7.15

ug/l

0.56

135

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

143

1.75

1.88

1.2

1.1

1.04

1.17

u/l

0.84

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

136

1.77

1.87

2.3

1.7

1.29

3.45

u/field

0.86

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.86

1.86

3.8

5.8

84.25

44.32

ug/min

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

107

1.87

1.86

2.0

1.5

39.55

40.76

g/l

0.48

107

(3042517) Benzodiazepines panel - Urine

4.17

1.82

2.4

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

247

1.54

1.78

1.3

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.34

1.77

1.4

1.7

—

(40757373) Influenza virus identified in Isolate

2.34

1.77

1.4

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

338

1.46

1.75

1.1

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

233

1.55

1.73

1.4

1.5

1.10

1.11

promille

0.02

184

(3011897) Casein IgE Ab [Units/volume] in Serum

2.67

1.72

1.1

0.07

1.08

u/ml

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1164

12333

0.91

1.72

2.0

1.9

1.43

1.38

mmol/l

1.24

989

10331

(3016244) Insulin [Units/volume] in Serum or Plasma

125

1.76

1.71

7.0

2.6

15.19

19.63

mu/l

0.74

119

(21494814) CD8 cells/Lymphocytes in Specimen

103

1.85

1.71

1.8

1.9

31.21

32.03

0.08

103

(3038177) Helicobacter pylori Ab [Presence] in Serum

390

1.42

1.70

1.2

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

126

1.75

1.67

1.1

1.9

13.02

10.43

nmol/l

0.09

111

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

293

0.54

1.67

1.1

1.0

28.73

42.48

ng/l

2.19

192

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.50

1.66

1.2

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

119

1.77

1.66

4.4

3.3

1.81

1.25

0.32

119

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1225

12934

0.92

1.65

4.7

5.8

2.48

3.39

ug/l

1.59

1092

11765

(3029634) Reagin Ab [Titer] in Serum by VDRL

359

1.43

1.65

1.8

2.2

—

6.60

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.44

1.64

1.1

10.29

9.08

mg/g

—

(3004775) Volume in Urine collected for unspecified duration

213

1.55

1.62

2.1

2.2

637.88

641.24

0.01

139

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.50

1.59

1.3

2.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.50

1.59

1.3

1.8

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

214

1.55

1.59

1.2

1.3

898.33

263.33

titre

—

(40768441) Liver Pathology biopsy report

207

1.55

1.56

1.4

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.43

1.53

1.5

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.43

1.53

1.5

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.43

1.53

1.5

1.2

—

(40768795) Lymph node Pathology biopsy report

290

1.45

1.52

1.2

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.34

1.52

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.60

1.51

2.9

2.2

—

(3016750) Collection duration of Urine

146

1.65

1.50

2.0

2.1

489.88

497.34

min

0.14

109

(3006442) Creatine [Moles/volume] in Serum or Plasma

178

1.58

1.48

1.7

1.4

85.54

82.76

umol/l

0.15

178

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.23

1.46

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

187

1.56

1.45

1.4

1.3

2.73

1.33

u/ml

0.35

103

(3023410) Appearance of Cerebral spinal fluid

294

1.43

1.3

1.7

—

(4024509) Urine culture

155

1301

1.20

1.40

2.2

1.9

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

177

0.51

1.39

21.1

19.7

1327.89

1347.30

nmol/l

—

169

(44806071) Cardiolipin IgM antibody measurement

2.42

1.39

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.94

1.36

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.04

1.32

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

3064

30260

1.13

1.31

48.8

22.1

132.23

136.65

g/l

42.44

3035

29856

(3022621) pH of Urine by Test strip

250

2198

1.15

1.30

2.8

2.6

5.86

6.06

3.23

185

1491

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.85

1.29

1.2

—

(40768800) Prostate Pathology biopsy report

939

0.78

1.29

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.36

1.29

1.5

1.8

—

(40765096) Chromosome analysis panel by Banding

1.76

1.28

1.1

1.2

—

(3011048) Pyruvate [Moles/volume] in Blood

2.78

1.28

1.4

1.1

108.00

91.67

umol/l

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

169

1.54

1.28

1.1

33.68

18.45

u/ml

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.89

1.28

1.3

1.2

2.69

1016.04

ug/l

—

(3004809) Band form neutrophils/Leukocytes in Blood

483

1.31

1.27

3.1

3.9

1.18

1.39

0.24

418

(3035941) MCH [Entitic mass]

3062

30250

1.12

1.25

48.2

21.9

30.51

30.46

0.87

3029

29839

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3062

30251

1.12

1.25

48.3

21.9

92.31

91.31

25.46

3030

29838

(3026361) Erythrocytes [#/volume] in Blood

3062

30252

1.12

1.24

48.4

21.9

4.39

4.52

e12/l

34.04

3013

29364

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.40

1.24

4.8

2.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.40

1.24

1.5

1.8

65.00

47.24

umol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.23

1.24

1.4

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3062

30253

1.12

1.24

50.9

22.3

39.91

40.93

4.70

3030

29827

(3007461) Platelets [#/volume] in Blood

3061

30243

1.12

1.23

48.5

22.0

233.28

247.68

e9/l

26.12

3013

29481

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

220

1.46

1.23

2.2

2.0

0.63

1.58

u/field

1.48

109

(3010813) Leukocytes [#/volume] in Blood

3062

30256

1.12

1.22

48.5

22.0

7.05

6.72

e9/l

10.03

3010

29366

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.31

1.18

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.88

1.18

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

722

1.24

1.17

1.2

—

(4146454) Self-monitoring of blood glucose

366

0.68

1.12

2.9

2.8

—

(3045414) Leukocytes [Presence] in Urine

305

2749

1.12

1.11

2.3

2.1

0.00

0.01

estimate

0.78

583

(3048879) Bone marrow aspiration report

1.78

1.10

2.3

1.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

373

1.32

1.07

1.2

1.1

15.19

19.42

au/ml

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.79

1.04

1.1

1.4

—

(44813793) Dust mix specific IgE antibody measurement

162

1.48

1.04

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

1.88

1.00

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

674

1.22

0.99

2.1

1.7

342.55

292.04

mu/l

0.55

625

(3032057) Clostridioides difficile [Presence] in Stool

1.84

0.98

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

292

1.34

0.97

4.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

267

1.35

0.96

1.5

0.19

0.27

nmol/l

0.97

206

(3036071) Salmonella sp Ab [Titer] in Serum

1.69

0.95

1.0

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

141

1.49

0.94

1.2

0.54

0.57

ratio

0.27

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

191

1.42

0.94

1.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.89

0.94

1.4

1.0

0.49

9.54

u/ml

—

(3019225) pH of Specimen

260

2867

0.90

0.91

5.4

4.0

7.35

0.11

211

1987

(4094501) Cardiovascular stress test using bicycle ergometer

773

1.20

0.91

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.07

0.89

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

775

1.19

0.89

1.8

2.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.65

0.88

1.6

53.23

712.01

nmol/24h

1.07

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

0.87

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

162

1.42

0.84

3.4

1.8

132.59

102.68

ng/l

1.30

162

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

179

1.40

0.84

1.0

1.1

0.09

10.27

nmol/l

—

(3020874) Milk IgE Ab [Units/volume] in Serum

121

1.49

0.82

1.1

1.0

0.37

1.03

u/ml

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

148

0.61

0.79

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

163

0.61

0.78

1.3

1.4

0.78

1.31

ratio

—

104

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

163

0.61

0.78

1.3

1.4

0.80

0.94

ratio

—

104

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

163

0.61

0.78

1.3

1.4

0.94

1.10

ratio

—

104

(3010144) Erythrocytes [#/volume] in Synovial fluid

269

1.30

0.77

1.3

230160.20

112030.67

e6/l

0.25

180

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

162

0.62

0.76

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

158

1.39

0.74

1.3

—

(40768793) Breast Pathology biopsy report

602

0.81

0.74

1.2

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

172

0.64

0.73

1.3

1.6

24.55

57.77

ug/l

—

146

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

150

1.40

0.73

6.0

7.9

22.46

236.18

ug/l

0.86

100

(4281824) Cell count and differential, peritoneal fluid

272

1.29

0.72

1.6

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.00

0.72

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

281

1.28

0.72

1.1

—

2.97

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

109

0.55

0.72

1.2

6.83

10.95

mm/h

—

109

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

380

1.24

0.71

1.9

2.3

859.11

3599.15

u/l

1.18

140

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

220

1.32

0.71

4.6

6.2

29.24

40.74

u/ml

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

282

1.28

0.71

1.1

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

143

1.40

0.70

1.0

1.1

86.19

81.36

u/l

0.13

130

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

143

1.40

0.70

1.0

1.1

21.15

26.13

u/l

0.23

129

(3029937) Albumin [Presence] in Urine by Test strip

862

8283

1.05

0.68

5.1

3.8

0.01

0.00

estimate

0.22

330

2828

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.67

0.68

1.1

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.67

0.68

2.4

2.1

18.84

20.28

umol/l

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

110

1.46

0.68

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

110

1.46

0.68

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

161

1.37

0.68

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

401

1.23

0.68

1.9

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

649

1.17

0.68

1.7

2.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

170

1.36

0.67

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

103

1.46

0.65

1.1

1.0

0.55

4.59

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

332

1.24

0.63

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

258

0.73

0.63

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

258

0.73

0.63

1.3

185.65

172.94

pmol/l

0.21

258

(3050129) First trimester maternal screen panel - Serum or Plasma

188

0.69

0.62

1.8

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

103

0.58

0.62

1.7

1.9

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.67

0.61

1.0

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.46

0.61

1.1

—

(4198724) Urine methamphetamine measurement

1.48

0.60

1.8

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1145

11120

1.04

0.59

4.7

3.7

0.02

0.08

estimate

0.83

311

2509

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.53

0.59

1.2

1.3

0.16

0.37

mmol/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

157

1.34

0.59

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

208

0.72

0.58

1.1

1.2

—

51.17

—

(1761482) Bacteria [#/volume] in Urine by Culture

720

0.86

0.55

4.8

4.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.62

0.55

2.8

2.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

611

0.85

0.54

4.3

3.2

34.22

28.03

mg/l

0.60

407

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.54

0.53

2.8

1.8

148.67

41.16

pmol/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.45

0.53

1.4

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

765

7924

0.96

0.53

2.8

3.3

0.84

0.79

ug/l

0.32

530

5284

(3000034) Microalbumin [Mass/volume] in Urine

260

0.77

0.52

2.9

3.1

40.91

31.44

mg/l

0.21

198

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

100

0.60

0.51

1.8

2.3

103.17

147.20

nmol/l

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

100

0.60

0.51

2.5

1.3

3.37

4.50

umol/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

135

0.67

0.51

1.2

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

136

0.66

0.51

1.2

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

179

1.29

0.51

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

324

1.21

0.50

3.1

3.9

64.00

56.36

1.40

260

(44806420) Estimation of glomerular filtration rate

258

0.77

0.50

2.3

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

759

7844

0.96

0.48

4.2

3.2

0.10

0.25

estimate

0.40

311

2416

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

128

1.33

0.47

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

824

0.88

0.46

1.6

—

(3033099) Centromere Ab [Titer] in Serum

1.43

0.46

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.38

0.46

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.38

0.46

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.38

0.46

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.38

0.46

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

356

1.18

0.45

1.3

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

118

0.68

0.45

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.60

0.45

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

130

1.31

0.44

1.9

2.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

697

1.12

0.43

1.5

1.4

11.30

8.64

u/l

0.80

566

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.41

0.43

1.4

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.61

0.43

2.2

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.38

0.42

1.2

35.22

40.06

g/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

670

1.12

0.42

1.4

93.60

15.45

e6/l

0.47

499

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.52

0.41

1.0

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

286

1.19

0.41

1.0

1.1

—

17.84

—

(4015189) Microbial culture of sputum

1.36

0.41

1.4

2.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

114

1.32

0.40

1.1

0.52

1.05

u/ml

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.47

0.40

1.4

1.1

3.99

9.31

u/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

1.27

0.40

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

3.78

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

2.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.38

0.38

1.4

1.1

15.31

15.67

umol/l

0.19

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

336

1.16

0.37

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.29

0.36

1.7

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.63

0.35

1.0

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

679

1.11

0.35

1.4

1.5

1178.76

639.98

e6/l

0.22

535

(3005988) Vibrio sp identified in Specimen by Organism specific culture

338

1.16

0.35

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.62

0.35

1.6

2.0

5.66

8.56

mg/l

—

(3028707) Methadone [Presence] in Urine by Screen method

310

1.16

0.35

4.2

2.5

—

(4211845) Urine protein measurement

133

0.75

0.33

1.4

3.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

817

1.09

0.33

1.5

29.89

28.96

iu/l

0.09

692

(3024522) Salmonella sp identified in Specimen by Organism specific culture

350

1.14

0.32

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

1.28

0.32

8.5

6.9

8.78

8.11

mmol/l

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.28

0.32

1.3

3.3

1.17

1.19

mmol/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

257

1.17

0.32

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.35

0.31

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

305

1.15

0.30

1.0

1.1

—

0.73

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

112

1.25

0.28

1.4

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

336

1.13

0.28

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.30

0.28

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.23

0.27

1.6

2.8

—

17.74

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

458

0.89

0.26

1.2

1.1

0.47

1.69

u/ml

2.13

257

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

235

0.85

0.25

1.2

1.1

—

78.50

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.27

0.24

1.3

1.5

59.03

54.99

ug/l

0.13

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

0.81

0.23

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

379

0.90

0.22

1.2

1.1

1.67

1.57

u/ml

0.04

173

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

354

3438

1.03

0.22

16.3

5.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

699

1.07

0.22

2.4

3.9

804.10

1065.44

u/ml

0.14

642

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

124

1176

1.06

0.22

3.0

3.8

88.24

83.02

u/ml

0.07

119

1140

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

125

1.20

0.22

1.7

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

410

0.90

0.22

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

248

1.13

0.21

1.1

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

409

0.90

0.21

1.3

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

28.78

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.98

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.21

0.0

1.4

—

4.36

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.04

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.39

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

304

0.89

0.21

1.1

3.01

2.12

eliau/ml

0.25

126

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.20

0.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.18

0.19

1.3

—

(3008898) HLA-B27 [Presence]

808

0.94

0.19

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

122

0.82

0.19

1.4

3.5

—

(3020491) Glucose [Moles/volume] in Blood

194

1.13

0.18

1.4

1.8

9.93

6.67

mmol/l

1.29

134

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.13

0.17

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

349

1.09

0.17

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.75

0.17

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

129

1.16

0.17

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

281

2885

0.97

0.17

1.5

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

120

0.83

0.16

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

476

1.07

0.16

6.8

2.9

—

(3016879) Cocaine [Presence] in Urine

672

1.06

0.15

3.4

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

555

1.06

0.15

3.3

2.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

119

0.84

0.15

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

149

0.87

0.13

2.5

1.5

26.77

28.66

umol/l

0.44

137

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

113

1.15

0.13

1.0

1.1

1338.46

1592.35

miu/ml

0.41

113

(1002224) Polysomnography panel

121

1252

0.97

0.12

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

142

1.13

0.12

1.4

19.69

25.26

umol/l

0.39

126

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

610

1.05

0.12

2.3

1.7

1.14

0.80

nmol/l

2.37

519

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

366

1.07

0.11

1.8

16.25

24.06

mg/l

—

117

(3003888) Timothy IgE Ab [Units/volume] in Serum

384

0.94

0.11

1.2

1.1

6.41

4.73

u/ml

0.29

204

(3027923) C peptide [Moles/volume] in Serum or Plasma

172

1.11

0.11

1.4

1.24

1.15

nmol/l

0.19

121

(3000764) Benzodiazepines [Presence] in Urine

720

1.04

0.11

3.3

2.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.13

0.09

1.1

—

4.96

—

(3019150) Specific gravity of Urine by Refractometry

650

6560

0.99

0.09

5.2

3.9

1.02

kg/l

0.71

461

4371

(3027008) Opiates [Presence] in Urine

725

1.04

0.08

3.3

2.0

—

(3028300) Cannabinoids [Presence] in Urine

727

1.03

0.07

3.3

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.04

0.07

6.9

2.3

9.81

10.31

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.04

0.07

6.9

2.3

5.90

4.82

kpa

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.84

0.07

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

295

0.95

0.06

1.1

2.28

4.84

u/ml

0.70

130

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.11

0.05

1.6

1.2

—

(3005570) Glucose [Moles/volume] in Urine

257

1.05

0.05

1.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

218

1.06

0.05

1.6

1.7

323.92

334.29

mu/l

0.06

174

(3013139) Helicobacter pylori Ag [Presence] in Stool

190

1880

1.01

0.04

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

161

1.06

0.03

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

616

6138

1.00

0.02

1.8

1.7

454.35

25054503.27

pmol/l

4.17

501

5085

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

882

0.99

0.02

1.8

1.9

230.80

211.95

pmol/l

0.53

837

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

259

0.96

0.02

1.1

1.0

0.23

0.37

u/ml

0.26

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

162

1.05

0.02

1.4

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

353

1.02

0.01

1.2

1.1

0.40

1.57

u/ml

2.63

180

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

246

0.98

0.00

1.1

1.3

2.31

2.08

mmol/l

0.30

235

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

276

0.98

0.00

1.4

1.5

892.43

997.87

mu/l

0.23

228

(3004616) Nuclear Ab [Presence] in Serum

316

0.98

0.00

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

609

1.00

0.00

1.4

—

(3027944) Amphetamines [Presence] in Urine

716

1.01

0.00

3.3

1.9

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

136

1.03

0.00

1.9

1.2

68.80

64.62

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

777

1.00

0.00

1.4

1.3

636.01

555.64

mg/l

0.74

747

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

137

1.02

0.00

1.0

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.94

0.00

1.0

12.32

43.95

iu/ml

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.87

0.00

1.3

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.6

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.2

—

365.40

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.9

—

3.00

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.52

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.00

-0.00

1.6

3.4

1.13

1.18

mmol/l

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.95

-0.00

1.9

2.4

6.57

145.20

ug/l

—

(3007733) Chloride [Moles/volume] in Urine

0.00

-0.00

0.0

1.5

—

60.33

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

562.07

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

-0.00

0.0

3.0

—

0.08

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

310

1.00

-0.00

1.2

1.1

3.93

2.31

u/ml

0.28

151

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3000285) Sodium [Moles/volume] in Blood

0.98

-0.00

1.3

1.1

138.17

139.18

mmol/l

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1933.00

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

64.14

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CARDMYOOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CARDMYOOTH	2.542 [2.24, 2.88]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.101

During the follow-up period (1.1.1998 — 31.12.2019), 1540 out of 5408 females with I9_CARDMYOOTH died.

Males

Parameter	HR [95% CI]	p-value
I9_CARDMYOOTH	2.934 [2.64, 3.26]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.034

During the follow-up period (1.1.1998 — 31.12.2019), 3551 out of 8905 males with I9_CARDMYOOTH died.

Mortality risk

Mortality risk for people of age

years, who have I9_CARDMYOOTH.

N-year risk	Females	Males
1	0.194%	0.628%
5	1.26%	3.754%
10	3.269%	9.214%
15	6.251%	17.151%
20	11.13%	27.492%

Relationships between endpoints

↥

Index endpoint: I9_CARDMYOOTH – Cardiomyopathy, other and unspecified

GWS hits: 10

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cardiomyopathy, other and unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints